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INTRODUCTION 
The pathogenicity of the canine herpesvirus (CHV) has 
been extensively studied and well documented as it relates 
to neonatal infections of the dog. There have also been 
experimental studies with CHV as it affects the adult dog, 
but the results of these experiments are conflicting. Some 
of the variation in results may be due to differences in 
viral isolates. As. yet only serological tests have been 
used to determine the interrelationships between various 
isolates of CHV. Until more extensive biochemical and 
biological studies are performed, we must assume that the 
various CHV isolates are antigenically related as shown 
by serum-virus-neutralization tests while recognizing that 
there may be strain differences detectable with other tests. 
A report of CHV being isolated from the respiratory 
tract of dogs with infectious canine tracheobronchitis and 
a subsequent report of the reproduction of this disease 
with the same virus (66) stimulated interest in the patho-
genicity of this virus in non-neonatal dogs. However, 
later reports by other workers (2), in which CHV was shown 
to cause only mild or inapparent respiratory infections, 
cast the CHV back into its previous role as a significant 
pathogen of only the neonatal dog. 
This study was designed to determine the pathogenicity 
of CHV-270 in non-neonatal dogs. Particular efforts were 
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devoted to the pathoqenicity of this virus for the genital 
tract partly because of the implications genital infections 
of adult dogs have in the transmission of CHV to neonatal 
dogs. The recent association of a CHV isolated in England 
from dogs experiencing stillbirths, abortions and infertility 
(90), was also a stimulus to study the effects of CHV-270 
on the genital tract of dogs. The pathogenicity of CHV-270 
for the respiratory tract was another aspect of this disease 
that was studied, Dogs infected with CHV-270 and maintained 
at normal environmental temperatures were compared with 
CHV-270 infected dogs maintained at varied environmental 
temperatures, 
In addition to the CHV-270 pathogenicity studies 
involving the genital and respiratory tracts of non-neonatal 
dogs, the immunological response to this virus was studied 
in an attempt to determine the role circulating neutralizing 
antibodies have on CHV infections of non-neonatal dogs. 
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LITERATURE REVIEW 
History of the Canine Herpesvirus 
The canine herpesvirus (CHV) was first isolated by 
CarmichaP.1., Fabricant and Squire in 1964 from the heart 
blood, lungs, livers, spleens and kidneys of two litters of 
~ups that were dying of a hemorrhagic disease that the 
authors thought was caused by a mycoplasma (27). A year 
later Carmichael, Strandberg, and Barnes reported that 
certain tissues from these pups that died contained 2 organ-
isms, a virus and a mycoplasma (29), The mycoplasma failed 
to produce cytopathic effects (CPE) in dog kidney cells 
(DKC) and it did not kill young pups inoculated orally and 
intraperitoneally, so thP.y concluded that the mycoplasma 
was not the etiological agent of this disease, They did, 
however, determine that the virus, which they identified as 
a herpesvirus and designated strain F-205, was the etiologi-
cal agent of the disease. This conclusion was based on the 
fact that bacteriologically sterile cell-culture fluid from 
DKC showing viral CPE, when inoculated orally or intraperi-
toneally, caused the typical pathologic changes in young 
r.uos characteristic of the original disease. In 1965 Stewart 
et al, (105) reported the isolation of CHV from dying neo-
natal dogs and in the same year Spertzel et al. (102) re-
ported the recovery of a ''herpes-like virus" from a dog 
kidney cell culture, 
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Since 1965 the CHV has been isolated from several cases 
of infant dog mortality (32, 37, 49, 58, 81, 91, 98), The 
isolation of CHV in the United States (12, 28, 65, 98, 101, 
102), England (32, 90, 91), Japan (79), France (38), and 
Australia (49, 58, 81) indicates that this virus has a 
world~wide distribution, 
In the past the primary importance of CHV as ~ patho-
gen has been in the disseminated disease produced in fetal 
and neonatal dogs. However, in common with herpesviruses 
of other animals, CHV has been shown to be an important 
~athogen of various organ systems in adult dogs. If one 
examines the herpesviruses of several of our domestic 
animals, a pattern of disease characteristic of this group 
of viruses can be observed, The pattern is one of fatal 
generalized disease of the fetus or the very young, mild 
upper respiratory infection and infection of the genital 
tract of older animals, and central nervou~ system infection, 
primarily, but not exclusively in the young. This pattern 
is seen with Herpesvirus hominis infections of man (99), 
H, bovis in cattle (11, 63, 70), equine herpesvirus 1 in 
horses (19, 19), and li· suis in swine (63), 
The Effect of Temperature on the Canine Herpesvirus 
The problem of why the CHV causes a fatal disease in 
neonatal pups while causing only relatively mild symptoms 
in adult dogs, has intrigued researchers since the CHV was 
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discovered. Andervont (1) working with li· hominis was the 
first to demonstrate that age was an important factor in 
the susceptibility of the host to infectious agents. 
The fatal outcome of CHV infections of neonatal pups 
is also typical of herpetic infections of newborn infants 
(99), newborn calves infected with H· bovis (11, 18, 53), 
and H. suis infections of piglets (18, 63), 
Johnson (62) proposed a cellular basis for the devel-
opment of resistance with age in H· hominis infections of 
mice. He ohserved that peritoneal macrophages from neo-
natal and maturo mice were equally susceptible to H. hominis, 
but that mature macrophages differed in their ability to 
release virus in that they would not infect other cells 
in contact with them, while infected neonatal mouse macro-
phages did infect other cells in contact with them. This 
ohenomenon was termed a ''barrier'', but the mechanism was 
not determined. Carmichael and Barnes (25) were unable to 
show any difference in the release of viFus from macro-
phages of neonatal or mature dogs, 
Carmichael et al, (26), in an attempt to evaluate 
intrinsic cell resistance and other factors that could 
exolain the greater virulence of CHU for the neonatal pup, 
were unable to attribute the sudden change from high sus-
ceptibility to high resistance, over a period of a few days, 
to macrophages or to the interferon system. These authors 
observed that there was no difference in "receptors" for 
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the CHV on cells of dogs of different ages, However, they 
were able to show that the multiplication of CHV in dog 
kidney cell cultures and in cultures of dog macrophages 
was markedly affected by the temperature at which viral 
replication was allowed to proceed. 
The effects of temperature on the growth of CHV has been 
well documented (7, B, 26, 76), Aurelian (7) was the first 
to n~serve that the multiplication of CHV was markedly 
affected by the temperature at which viral replication 
tonk place, The incubation temperature of CHV infected 
cell cultures that gave maximum yields of infectious virus 
was between 35 and 37 C (7, 25), This optimal range for 
virai multiplication is below the normal temperaturei 38,9 C 
(102 F) (42), of the mature dog, however, this range of 
35 - 37 C approximates the body temperature of neonatal 
pups raised at ambient temperatures between 21 and 27 C (25), 
CHU infected dog kidney and dog macrophage cultures incu-
bated at 38 C (the normal rectal temperature for pups that 
have developed thermoregulatory control (47)) yielded 
approximately 10 percent as much virus as cultures incu-
bated at 35 C (25). At 39,5 C virus yield was less than 
D.1 percent of the maximum (25), The elevated temperatures 
affect viral replication specifically, since1 uninfected 
cells survive and multiply at 42 C (25), 
The mechanism of inhibition of CHV multiplication at 
elevated temperatures has been studied and it appears that 
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the thermosensitive stage is late in the growth cycle (76, 
1~3), lust and Carmichael (76) observed that viral DNA 
and proteins were synthesized at 40 C and they suggested 
that the reason the formation of infectious virus was 
blocked at elevated temperatures wa~ faulty matura-
tion or assembly of the virus. In contrast, Stevens (103) 
observed that H, bovis viral soecific proteins were synthe-- . 
sized at 42 C but synthesis of viral DNA could not be de-
tected, Ye therefore conclud~d that the blocking of a 
temperature-sensitive step precludes the synthesis of viral 
DNA and therefore th~ formation of mature viruses, This 
author hypothesized that either the formation of a specific 
virus-induced DNA polymerase might be inhibited by heat, or 
that a stRp following viral uncoating, which involves a 
change in the infecting DNA so that it can be replicated, 
could be heat sensitive. Using temperature "shift down'' 
experiments, Stevens was able to show that the blocking 
step occurred one hour after infection. In addition he 
showed that the virus induced an increased activity of a 
unique DNA polymerase at 37 and 42 C, Stevens concluded 
that the heat-sensitive step is concerned with an essential 
change either in the intracellular location or in the 
physical state o~ the infecting DNA molecule, 
Studies of the thermal balance of new-born pups have 
shown that during the first 2 weeks of life the neonatal 
pup is unable to regulate its body temperature (34, 35, 47). 
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Crighton (34) summarized the situation in the neonatal pup 
by stating that "The newborn puppy in it~ usual environment 
is seen as a true homiotherm whose Lower Critical Tempera-
turP. is so high that it is born into its own Zone of Hypo-
thermia, and in order to maintain a steady high rectal 
temperature it substitutes for its lack of compensatory 
thermogenesis, compensatory thermal conduction," By the 
third to the seventh day of life compensatory heat production 
in the face of heat loss begins to overtake the role of 
thermal conduction and by the seventh day the pup is able 
to withstand temperatures down to 11 C (34). The shivering 
response has been observed in pups at 6 days of age (34); 
however, temperature homeostasis does not become fully oper-
ative until the third week of life (26), 
Carmichael et al, (26) observed that during the first 
week of life, pups reared with their dams at a temperature 
of 21 t had body temperatures 1,7 to 4.4 C (3 to 8 F) lower 
than adult dogs, Knowing that neonatal pups have a rela-
tively low body temperature, which they are unable ta fully 
regulate until approximately.the third week of life, and 
knowing that the CHV is very heat sensitive, these authors 
proposed that lower body temperature might be an important 
factor in the pathogenesis of CHV, Schmidt and Rasmussen (97) 
working with mice found them more resistant to li· hominis 
when reared at 37 C rather than 24 C, The lower percent of 
mortality was attributed to a lower concentration of virus 
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in the brains of these mice. Neonatal pups reared in a 
heated environment that caused elevation of their body 
temperature equal to that of an ad~lt dog had increased 
survival rates following CHU infection and viral growth 
was reduced (26). Studies using 4-to 8-week-old dogs 
provided more evidencs for the role of body temperature 
in modifying the symptoms, lesions, and viral multiplica-
tion of CHU in dogs (26). In these studies it was observed 
that doos having artificially lowered body temperatures 
yielded virus from the liver, spleen, and kidneys, whereas 
no virus was isolated and lesions were absent in litter-
mates whose body temperatures were not reduced, The fact 
that cells of non-neonatal dogs would support viral growth 
supported previous findings that viral multiplication of 
CHU was essentially equal in macrophages from 2-day-old 
and from 10-week-old pups, 
Carmichael et al, (26) observed that the growth of 
CHU in mature animals seems to be restricted to the cooler 
portions of the body, These authors, using a thermistor 
needle-probe, measured the temperatures of the various 
external orifices and internal organs. The areas in which 
CHU has.been identified as growing in the mature dog all have 
lower temperatures than the normal body temperature of the 
mature dog. For example, the temperature of the nasal 
cavity was found to be 3 to 4 C cooler than the normal 
body temperature; 
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The body temperature may also have an indirect effect 
on herpesvirus infections, Leucocytes have a definite 
function in destroying herpesvirus in the presence of 
immune serum (60), This together with the fact that there 
is a stimulatory influence of elevated temperature on 
phagocytic activity (55), suggests another mechanism by 
which body temperature may influence CHV infections, 
The capacity for an inflammatory response is important 
in determining the pathogenesis of a CHV infection, 
Inflammatory reactions have not been observed around 
necrotic foci found in natural cases or in artificially 
infected pups that died of a CHV infection (28). In another 
study only pups that survived longer than 2 weeks had 
microscopic lesions th~t indicated that an inflammatory 
response was present (26), The febrile response is vir-
tually absent until the pup is 2 to 3 weeks old (26), 
Carmichael et £!..l. (25) concluded that both regulation 
~f temperature and the capacity for inflammatory and fe-
brile responses are important factors that relate to the 
pathogenesis and recovery processes of CHV infections in 
young pups, 
Herpesvirus Infections of Neonatal Pups 
The CHV has been isolated from numerous tissues of neo-
natal pups which died of a disease characterized by dissem-
inat9d focal necrosis and hemorrhage (22, 29, 91, 98, 105), 
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Susceptible pups acquire the infection through contact 
"ith infected dogs (57), Stewart et al. (105) have reported 
~''V infectinn in pups obtained by Caesarean section from 
apparently normal bitches. Thus, pups may be infected 
in utero via trans placental infection. Pregnant bitches 
incculatRd intravaginally 2 weeks before whelping, have pro-
~uced pups with fatal CHV infections (22), Carmichaei (23) 
reported that it is probably more common for a litter of pups 
to be infected while passing through the birth canal of a 
tJi.tch recently exposed to the virus than by in utero 
infnctinn. 
The grnss pathological changes in CHV infected pups 
are similar in both natural and experimental cases (31), The 
lesions consist of hemorrhages and widespread focal necrosis 
., 
that involve not only parenchymal and stromal cells but 
also blood vessels (23), The lesions are found in virtually 
all tissues (23), and by the fluorescent antibody technique_ 
·virus has been demonstrated in virtually every tissue 
examined (113), However, lesions are especially noticeable 
in the liver, kidney, lungs, adrenal glands, intestines, 
and turbinates (57, 113), Changes in the kidneys are 
especially severe and the characteristic renal hemorrhages 
are cnnsidered of diagnostic significance (31). These le-
siane in tho kidney consist of cortical necrosis and 
hemorrhages, which appear as circumscribed red areas on a 
dull gray backgrnund (23, 31). Cornwell and Wright (31) 
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stated that the lungs are usually edematous with frothy 
blcodstained fluid in the bronchi and trachea and there are 
multiple small hemorrhages scattered throughout the lobes. 
He~orrhages. are commo~ly found in the intestine, gastric 
mucosa and liver (31), The liver occasionally will have a 
few yellow foci on the surface (23), 
Wright and Cornwell (115) reported that under experi-
mental conditions, neonatal pups ate highly susceptible to 
infection with CHU by the intranasal route. These authors 
noted that the main lesion was a focal necrotizing rhinitis 
which appeared as early as 2 days after infection in sus-
ceptible pups kept in contact with experimentally infected 
litter-mates, They concluded that the nasal mucosa was 
an important portal of entry for the CHU and that CHU gains 
access to the bloodsteam early in the course of the disease 
by extension of the necrotic process through the nasal 
epithelium and involvement of the blood vessels in the 
Underlying lamina oropria, 
Clinical signs of central nervous system involvement 
have not been reported in pups naturally infected with CHU, 
but it has been shown that experimental inoculation by the 
intranasal, intracerebral, or intraperitoneal route will 
cause meningoencephalitis (87). Percy et .!U_, (87) stated 
that, depending on the course of the dis~ase, lesions may 
vary from discrate foci of neuronal degeneration, micro-
gliosis, and perivascular cuffing, to diffuse hemorrhagic 
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meningoencephalitis characterized by necrosis, cavitation, 
and hemorrhage. 
Percy et al, (85) have described the lesions in pups 
that have survived infection with CHV, These authors found 
that experimentally CHV-infected pups that subsequently re-
covered from the disease had focal granulomatous encephalitis, 
interstitial pneumonitis, and segmental renal necrosis with 
dysplasia. They also reported that pups which recovered 
from naturally occurring infections had segmental cerebellar 
and retinal dysplasia. 
The gross and histopathologic findings of natural and 
experimental cases of CHV infections in neonatal pups have 
been well reviewed in the literature (24, 28, 84) and will 
not be discussed further. 
Canine Herpesvirus Infection in Non-neonatal Dogs 
The major emphasis of CHV research has been concerned 
with the disease it causes in the neonatal pup, However, 
recent isolations have been made from adult dogs with a 
variety of conditions and it appears that a better under-
standing of all the disease conditions CHV causes is 
needed before the complete impact of this virus on the 
canine population can be ascertained, CHV has been isolated 
from kidney cell cultures prepared from normal pups (101, 
102), from dogs with upper respiratory tract disease (12, 
67, 68), from a pup (2) and an adult dog with distemper (7g), 
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fro~ a dog with malignant lymphoma (65), from apparently 
healthy dogs (C:7), and from the genital tracts of dogs with 
a history of infertility, abortion, and stillbirths (90). 
Si~-week-old puos which have had CHV inoculated into the 
conjunctival sac have shown signs of mild conjunctivitis 
with chemosis and serous ocular discharge (31). 
The literature contains reports of negative results 
or mild disease resulting from experimental inocuiations 
nf CHV by various routes in the non-neonatal dog. Appel 
et al. (2) exposed 29 .young ~agle dogs to CHV 
hy the oral-nasal route and reported either mild or in-
apparent respiratory infections. These authors also re-
ported that oral-nasal and intravaginal inoculation of 
dngs older than 2 weeks of age caused only mild inflammation 
of the upper respiratory tract and vaginal mucosa respective-
ly, and that viral growth was restricted to these tissues, 
except for occasional transient leukocyte-associated 
viremia. Huxsoll and Hemelt (57) reported that they were 
unable to produce clinical disease in susceptible 5 and 8-
month-old dogs experimentally infected with CHV. 
Canine respiratory infections are common in epidemic 
fnrm wherever dogs are housed together. One respiratory 
condition which has been a problem in animal hospitals and 
other institutions where large numbers of dogs are housed 
together, is infectious canine tracheobronchitis, also 
termed "kennel cough," The outstanding sign of this disease 
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is a cough manifested by a short, dry "hack" or by a series 
of such coughs (23), Kar pas et al. (68) reported the 
isolation of a herpesvirus from a group of dogs with 
infectious canine tracheobronchitis, From the same group 
of dogs, Karpas et al, (68) were able to isolate CHV from 
dogs showing no clinical signs characteristic of the disease, 
Karpas et J!l, (66) reported a variable clinical course of 
respiratory disease in experimental dogs inoculated intra-
nasally. All the dogs had rhinitis to a variable degree 
and sneezed occasionally. Sporadic coughing could be 
caused in 2 dogs by palpating the trachea; another dog had 
a paroxysmal cough which lasted for 2 weeks, In another 
group of 8 dogs inoculated intranasally with CHV, they re-
ported a spontaneous cough in 3 dogs (66), This report is 
in contrast to the findings of Appel et al. (2), who re-
ported that 48 hours after inoculation with CHV by the oral-
nasal route the dogs only had a mild rhinitis with a scant 
amount of serous nasal discharge. Appel et al. also re-- -
ported that some dogs developed a mucoid nasal discharge after 
3 to 4 days, Occasionally sneezing was observed in several 
of these dogs between the 4th and Bth days postinoculation, 
However, none of these dogs coughed, and coughing could 
nr.t be induced by palpating the trachea, The gross lesions 
in these dogs bonsisted of hyperemia of the nasal turbinate 
mucosa and slight reddening of the posterior pharynx of 
dogs. killed between the 2nd and 6th days postinoculation, 
I 
! 
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Lung lesions consisted of a moderate increase in the 
number of interstitial cells and there was some thickening 
of interalveolar septa. A few polymorphonuclear leukocytes 
and m~crophages were seen, increasing the cellularity of 
aJ.veolar walls •. 
Wright tl al, (118) have reported the isolation of CHV 
from a neonatal dog in the United Kingdom. Experimental 
inoculation of this virus into susceptible 6-week-old pups 
did not cause any clinical symptoms, However, at post-mortem 
examination, they observed focal necrotizing pneumonia in 
the experimental pups, These authors suggested that CHV 
does not cause overt signs of respiratory disease; but like 
other herpesvirus infections, CHV might exist in the adult 
dog population in a latent state and is associated with 
respiratory disease only in times of stress, 
~any other agents have been isolated from dogs with 
respiratory disease, Binn et al. (12) reported isolation 
of canine adenoviruses, a canine herpesvirus, and a SV-5-like 
virus from dogs with respiratory disease, The importance of 
a SV-5-like parainfluenza virus in respiratory disease of 
dogs has been supported by other investigators (3, 14, 33, 
94). Appel et £!1. (4) reported that in their study only SV-
5-like virus was isolated from dogs with a dry cough~ These 
dogs were immune to canine distemper and infectious canine 
hepatitis. These authors also found that the SV-5-like 
virus in combination with Bordetella bronchiseptica and a 
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myc~plasma caused a harsh dry cough which was more severe 
than when the virus was used as the sole inoculum. However, 
SV-5 virus w~s not isolated from all cases of dogs with the 
cough. Similarly canine adenovirus type 2 has been iso-
lated repeatedly from dogs with respiratory disease (12, 
21, 39), and respiratory diseas~ has been produced with 
this virus (107, 117); Two other viruses that have been 
suggested as possibli etiological agents of infectious 
canine tracheobronchitis are canine distemper and reovirus 
type 1 ( 4). 
There are numerous reports of isolations of mycoplasmas 
from dogs with respiratory disease (3, 5, 14, 52). However, 
clinical disease has never been produced with mycoplasma 
alone in dogs (4). Mycoplasmas have frequently been iso-
latRd from dogs without signs of disease (4). 
In 1970, in a review of the current status of canine 
respiratory disease, Appel tl al. (4) concluded that 
possibly more than one virus is involved in infectious 
tracheobronchitis and that the presence of potentially 
pathogenic bacteria including the mycoplasma, added to the 
severity of this disease. 
The Pathogenicity of the Canine Herpesvirus 
for the Canine Genital Tract 
Appel et.al. (2) reported that dogs infected by the 
oral-nasal route with CHV developed a mild inflammation of 
the vaginal mucosa. Paste and King (90) in Britain described 
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t'i<:> first isolation of a CHV from naturally-occurring 
infections of the genital tract of male and female dogs. 
These infgctions wB'!'e associated with a clinical histnry of 
i~fertility, abortion and stillbirths. The CHV isolated 
Prem this outbreak of genital infections was used to produce 
the same clinical condition in one of 3 female dogs inocu-
lat0d intravaginally. The lesions in both the natural and 
oxporimental cases consisted of vesicular lesions that 
~ecame circula~ and "pock-like.'' The lesions were found in 
the vestibule, cnmmonly in the. region of the urethral ori-
fice, hut lesions were present on most surfaces of the 
vagina in severe cases. In the male dogs the lesions were 
nn the preputial mucosa and on the penis at the preputial 
reflection, Paste and King (90) recognized and reported 
the similarity of the lesions they observed to those re-
ported previously in cases of so called ''dog pox" (20, 72). 
The etiology of "dog pox" is unknown although infectious 
agents have been implicated (20). It has been reported 
that in addition to the genital lesions of primary "dog 
pox,'' the gum margins, gastrointestinal tract, anus, and 
conjunctiva were also affected on occasion (20), Support for 
the possibility that the etiological agent of "dog pox'' 
is a herpesvirus is the fact that these sites of infection 
described above are known predilection and replication sites 
for herpesvirus in several species (88). 
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Several interesting features of the outbreak reported 
by Poste and King (90) are important not only to the under-
standing of the disease CHV causes in the genital tract of 
dogs but also to the epizootiology of the CHV complex in 
dogs, They reported that the CHV genital infections were 
transmitted by sexual contact and they also demonstrated the 
CHV in the genital tract of female dogs. These findings 
explained how the infection of the neonatal pup occurs 
during its passage through the birth canal. The reports 
also contained the first evidence that latency and recurrent 
infections may occur with CHV. Other workers (2, 31, 66, 
105) have suggested recurrent and latent CHV infections and 
these phenomena are well-known features of herpesvirus 
infections of some other species of animals (88). 
Poste (89) in a subsequent report, in which he charac-
terized the CHV that was isolated from the genital tract of 
dogs (90), stated that although CHV-BR (Posts strain) is 
serologically very similar to the CHV strain F-205 isolated 
by Carmichael et al. (29), it differs from this strain by 
virtue of the CPE in DKC. CHV-BR causes the formation of 
polykaryocytes that have not been reported for othei strains 
of CHV (89). Paste (89) also reported thrit the incidence 
of nuclear inclusions in DKC infected with the CHV-BR strain 
was considerably higher than that reported for other CHV 
strains. He also stated that these differences may reflect 
significant differences between the CHV strains but it is 
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possible that the site of virus isolation from the body might 
influence the type of CPE. Dowdle et al. (41) have observed 
an association of ~ntigenic type of li· hominis with the 
site of viral recovery in man. They reported that there 
were 2 antigenically distinct groups of li· hominis which 
they designated type 1 and 2. All 42 strains which they 
identified as type 2 were isolated from herpetic infections 
related directly or indirectly to the adult genital tract, 
w~ereas, type 1 was isolated from sites other than the 
genital tract. Other workers have. identified herpesviruses 
which are variants of a strain (45) or two separate strains 
of the same virus (111) on the basis of CPE induced. It has 
been reported that for the most part, li· hominis variants 
based on plaque morphology of CPE on various tissue culture 
systems are antigenically identical to the parent strain (BO) • 
. Immunological Aspects of the Canine Herpesvirus 
The antibody response to CHV in adult dogs has been 
studied by Karpas §.1 al. (57). These workers found that 
the levels of neutralizing antibody in naturally-infected 
dogs were variable, with negative titers possibly being 
a reflection of inadequate exposure to the CHV for the 
neutralizing antibodies to develop. Experimentally-infected 
doas developed significant titers of neutralizing antibody 
after intranaaal inoculation. Antibody titers were detec~ed 
as early as 17 days after initial inoculation and they in-
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cr~ased t~ a neak at one month, Beyond one month the titers 
gradually decreased, Neutralizing antibody titers to CHV 
have been reported as·high as 128 (67), Different tech-
niques used to determine neutralizing antibody may cause 
variation in reported titers from different laboratories, 
It has boen reported that the constant serum-varying virus 
(al~l1a) procedure is the most sensitive method (24). The 
addition of guinea-pig complement to the virus-serum 
dilutions has been reported to increase CHV neutralizing 
antibody titers two-to-eightfold (24). Complement-requiring 
neutralizing antibody to li· hominis in man appears one week 
after infection and reaches a considerable level before 
rises of complement fixin·g and non,.complement-requir.ing 
neutralizing antibody (119), The complement-requiring 
neutralizing antibody is used in man for early detection 
of herpetic infections which are difficult to identify 
otherwise, since a large portion of the population has circu-
lating antibodies to herpesviruses (119), . There are no 
extensive serological surveys reported to indicate the 
extent of CHV in the canine population, However, Spertzel 
et !Ll_. (102) reported that antibody to CHV had been found 
in three lots of commercial canine globulin, The use of 
complement-requiring neutralizing antibody possibly could 
be important in identifying early cases of CHV antibody, 
The relationship between neutralizing CHV antibody titers 
and immunity has not been established in adult dogs, but it 
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has been reported that maternal antibody will protect neo-
natal pups from the disease but not from the infection 
(24, 57). It has been suggested that it is CHV maternal 
antibodies that protect litters of pups born to bitches 
that have had a previous litter die of a CHV infection (57), 
Newborn pups that suckled from bitches with neutralizing 
antibody titers of 1:4 or greater showed no signs of illness 
after being inoculated orally or intraperitoneally with 
CHV (24). Although any apparent illness was absent, virus 
~as recovered from the nasal, pharyngeal and rectal speci-
mens taken from these pups, 
Carmichael (24) suggests that neutralizing antibody 
titrirs are not always a good indication of resista,nue 
because neutralization of CHV by antibody is probably a 
poor indication of the biological adthddi.y ·of an.tibodies, 
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MATERIALS AND METHODS 
Cell Lines 
MOCK cells 
The Madin-Darby canine-kidney (MOCK) cell line was 
used for propagation of all CHV and canine adenovirus, for 
viral isolation, and for serum-virus-neutralization tests 
(SVN). The MOCK cells were propagated at 37 C in 250 ml 
plastic:tissue-culture flasks. 1 The growth medium consisted 
of minimum essential medium (Eagle) with Earle's salts and 
L-glutamine plus 10 percent bovine serum and 0.11 percent 
sodium bicarbonate. Monolayers of cells were trypsinized 
with··o.2 percent trypsin-versene (see preparation next page), 
diluted 1 to 3 in growth medium and dispensed into disposable 
glass tissue-culture tubes, 2 plastic tissue-culture plates, 3 
and Leighton tissue-culture tubes • 
.!..Q!!!. passage Q.!5.£ cells 
Dog kidney cells (DKC) 4 between the third and sixth 
passages were propagated using the same growth medium as 
1Falcon Plastics, Los Angeles, California. 
2Becton, Dickinson and Co,, Rutherford, New Jersey. 
3Linbro Chemical Co., New Haven, Connecticut. 
4obtained from Dr. Arnett Matchett, u. s. D. A., 
Biologics Division, Ames, Iowa. 
I 
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was used for the MOCK cells. These cells were grown in 
glass tissue-culture tubes and were only used to compare the 
sensiti~ity of OKC and MOCK cells to CHV-270. 
Maintenance Medium 
Minimum essential medium (MEM) (Eagle) with Earle's 
salts and L-glutamine plus 2 percent bovine serum and 0.11 
percent sodium bicarbonate was used for the maintenance of 
the cell-culture monolayers and for cell washing. 
Water 
The water used in all procedures and solutions was 
glass distilled and deionized. It contained less than 0.5 
_,ug/ml of sodium chloride equivalents as measured with a con-
ductivity meter.1 
Trypsin-Versene Solution 
A trypsin-versene solution was used to remove the DKC 
and MOCK cells from the surface of the 250 ml plastic flasks. 
The formulation was as follows: 
Trypsin 2 (1:250) 
Na Cl 
KH2P04 
Na2HP04 
H20 
Ethylenediamine 
Tetraacetic acid 
Tetra sodium salt 
2.0 g 
8.0 g 
0.2 q 
1 .15g 
1 • O liter 
1. 0 g 
1Barnstead Company, Boston, Massachusetts. 
2Difco Laboratories, Detroit, Michigan. 
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Pucks Saline Solution G 
Pucks saline solution G (92) was used as the diluent 
for all virus dilutions. The formula for this solution is 
as follows: 
Water 
Glucose 
Phenol red 
Na Cl 
K Cl 
NazHP0407H20 
K H2P04 
lllg S04 •7H20 
ca c12 .2H 2o 
Viruses 
Canine herpesvirus, strain F-205 
1.0 liter 
1 .1 g 
5. O mg 
B. 0 g 
0.4 g 
0.29g 
0.15g 
0 .15g 
16. 0 mg 
Canine herpesvirus strain F-2051 at the fifth passage 
level on DKC was propagated on lllDCK cells in 250 ml tissue-
culture flasks. The cell-culture fluid containing virus 
and cells was harvested when the CPE was nearly complete. 
I Viral suspensions were frozen in liquid nitrogen and thawed 
to release the virus from the cells, centrifuged at 115 x g 
then stored at -90 C. CHV strain F-205 at the second 
passage level on lllDCK was used in the cross-neutralization 
test with CHV-270 and for comparison of the CPE produced by 
CHV strain F-205 and CHV-270. 
1 obt~ined from Dr. L. E, Carmichael, Cornell University, 
Ithaca, New York. 
I 
.. ·;·_, 
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Canine herpesvirus isolate .z1.Q (CHV-270) 
CHV-2701 was isolated by Dr. A. Karpas from a clinical 
case of infectious canine tracheobronchi tis. This virus 
had been passed 3 times on MDCK when received in our labora-
" 
tory. The virus was passed further on MDCK cells, harvested, 
and stored at -90 c. CHV-270 at the 4th and Sth passage 
levels was used to inoculate dogs in experiments 1 through 
4 and experiments 6 through B. CHV-270 was also used as 
the challenge virus in experiment 5 and as the antigen in 
the preparation of the anti-CHV rabbit serum. 
Temperature-attenuated canine herpesvirus isolate 270 (CHV-33) 
CHV-331 is the CHV-270 isolate which when received had 
been passed 8 0 times on MOCK at 33 C. This virus was passed 
to the 91st passage level on MDCK at 33 C, harvested and 
stored as described for CHV strain F-205 •. CHV-33 was used 
at the 83rd passage level to inoculate the dogs in experi-
ment s. 
Canine adenovirus, A26/61 strain 
The canine adenovirus strain A26/612 was isolated by 
Ditchfield tl tl• (39) from experimental surgery.doos experi-
encing "kennel cough.'' This virus was received after 10 
1obtained from Dr. G. P. Shibley, Haver-Lockhart, 
Shawnee Mission, Kansas. 
2Dbtained from Dr. L. Swango, Auburn University, Auburn, 
Alabama. 
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passages on DK cells, passed once on mDCK, harvested and 
stored as described previously, Canine adenovirus, strain 
A26/61 was used in a SVN test to check for the presence of 
canine adenovirus antibodies in serums randomly selected 
from dogs iniexperiments 4, 5 and 7, 
Nutrient Agar-Overlay medium 
A double concentration of Eagle's basal medium (BmE) 
with Earle's salts supplemented with 10 percent bovine 
serum and 0,22 percent sodium bicarbonate was added to an 
equal vol~me of 1.B percent "Ionagar" #2. 1 Just prior to 
using this agar-overlay medium in the 35 x 10 mm wells of 
plastic tissue-culture plates, 10,000 units of penicillin 
and 10,000>.rg of streptomycin were added to each 100 ml 
of the medium. The final concentration of each component 
was 0,9 percent agar, 5 percent bovine serum, and 0,11 per-
cent sodium bicarbonate, 
Neutral-Red Agar-Overlay medium 
When virus plaques appeared in the cell monolayers 
grown in plastic tissue-culture plates, a second agar-
overlay was added to differentiate the plaques, This agar-
over lay medium contained 1 percent ·"I onagar" #21 and 1 0 
mg per 100 ml of neutral red, After adding this second 
agar-overlay, the plates were placed in the dark for 8 
1oxoid marketed by Colab Labora,tories, Inc. Chicago 
Heights, Illinois. 
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hours to allow vital staining to occur. The plaques were 
then counted. 
Virus Titration 
Tenfold serial dilutions of the virus to be titrated 
were made in saline c. One half ml of each dilution of 
virus was inoculated into each of two 35 x 10 mm wells of 
a plas~ic tissue-culture plate, containing a 4-day-old 
monolayer of mDCK cells. The virus was allowed to adsorb 
for 2 hours at room temperature be fore being aspirated. The 
inoculated cell monolayers were then overlayed with 2 ml 
of nutrient agar-overlay medium per well. The plates were 
incubated at 37 C until plaques became visible. To aid 
in the differentiation of plaques the neutral-red agar-over-
lay was added. The plaques were counted and the titers of 
the virus were expressed in plaque-forming units (pfu) 
per ml of virus. 
Preparation of Anti-CHV Rabbit Serum 
The CHV antigen was prepared by inoculating a 4-day-old 
mDCK cell culture with CHV-270. When approximately 75 
percent of the cells showed CPE, they were scrape'd from the 
surface of the flask and suspended in cell-culture medium. 
To release the viral antigen from the cells, the suspension 
was twice frozen in liquid nitrogen and thawed. In order to 
remove the cellular debris the suspension was centrifuged 
. ·.:-··, -· 
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at 2,000 x g for 30 minutes and the supernatant CHU antigen 
was then stored at -90 c. 
Two young New Zealand white rabbits were used in pre-
paration of the antiserum. For intravenous (IV) injection, 
undiluted CHU antigen was thawed and used immediately. 
The lateral ear vein was used for IV inoculations. For 
intradermal (ID) inoculations of the CHU antigen, the anti-
gen was mixed with equal parts of Freund~s complete adjuvant.1 
An emulsion of the antigen and adjuvant was prepared by 
adding 0,5 ml of antigen, drop by drop, to the adjuvant and 
agitating vigorously. The ID inoculations were made along 
the back of the rabbit, 0.2 ml at each site. Each rabbit 
was inoculated IV with 1 ml of the undiluted virus on days 
1, 2, and 4 and ID with the emulsion on days 1, 7, 14, and 
21. Both rabbits were bled on days 28 and 35. The blood 
was collected from the heart, allowed to clot at room 
temperature for 1 hour, refrigerated at 4 C overnight and 
then centrifuged at 275 x g to separate the serum from the 
clot. The serum was then removed from the clot, heat 
inactivated for 1 hour at 56 C, and stored at -20 C. 
Serum-Virus-Neutralization Tests 
The serum-virus-neutralization (SUN) test was used 
to determine antibody titers to CHU and canine adenovirus. 
Twofold dilutions (to a dilution of 1/512) of the serum to 
1Difco Laboratories, Detroit, Michigan. 
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be tested were made in saline G. Virus which had been pre-
viously titrated was diluted so that the final concentration 
would contain approximately 100 pfu per well. Equal amounts 
of virus and serum war~ mixed and incubated at room tempera-
ture for 1 hour. One half ml of each dilution of the 
serum-virus mixture was then inoculated into each of two 
35 x 10 mm wells of a plastic tissue-culture plate, contain-
ing a 4-day-old monolayer of mDCK sells. The virus was 
adsorbed and then aspirated as described for virus titration. 
Two ml of nutrient agar-overlay was added to each well and 
when plaques appeared 2 ml of a neutral-red agar-overlay was 
added to aid in the counting of the plaques. The antibody 
titers were expressed as the reciprocals of the serum 
dilutions which produced 50 percent reduction in the number 
of viral plaques when compared with the number of ~laques 
in the control plates. 
Special Staining Procedures 
mDCK cell-cultures grown on coverslips in Leighton 
tubes were used to propagate CHV strain F-205 and CHV-270. 
When between 25. and 50 percent of the cells showed CPE 
the coverslips were removed and stained as described below. 
"Acridine orange staining procedure 
The acridine orange staining procedure (36) was used 
in an attempt to differentiate between the number of 
intranuclear inclusion bodies produced by the CHV-270 and 
\-
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the CHV strain F-205. Acridine orange stained cell cultures 
were examined using an ultraviolet microscope. 
Hematoxylin-phloxin-safran staining procedure 
The hematoxylin-phloxin-safran staining procedure (110) 
was used to study the difference between the types of CPE 
produced by the CHV-270 and the CHV strain F-205. 
Nuclear Feulgen reaction 
The nuclear feulgen reaction (74) was used to stain 
MOCK cell cultures infected with CHV-270 and CHV strain 
F-205, in an attempt to demonstrate a difference in the 
number.of intranuclear inclusion bodies produced by these 
two virusas, 
Blood Parameters 
One ml of blood was withdrawn from the cephalic vein 
of dogs and collected in Vacutainer tubes1 containing 
ethylenediaminetetraacetic acid. The packed cell volume 
(PCV) of the blood samples was determined using the micro-
hematocrit method (96). White blood cell (WBC) and red 
blood cell (RBC) counts were determined using a Coulter 
Counter2. The hemoglobin concentration of the blood samples 
w~s measured using the spectrophotomet{c method (96). 
1Becton, Dickinson and Co., Rutherford, New Jersey. 
2Coulter Electronics Co,, Hialeah, Florida. 
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Collection of Specimens 
Cotton-tipped applicators (cotton swabs) were used to 
obtain specimens for viral isolation from the nasal cavity, 
conjunctival ~ac, pharynx, and genital tract (vagina or sheath), 
The cotton swab was inserted into the desired site and 
gently rotated so that as much of the swab as possible con-
tacted the tissue. The cotton swabs were then put into 
tubes containing 2 ml of antibiotic "cleaning fluid'' 
(formulatio~ next section), After all the specimens were 
collected the cotton swabs were pressed against the side of 
the tubes to remove as much of the fluid as possible, The 
swabs were then discarded and the fluid was used for viral 
and mycoplasmal isolations. Specimens for viral isolation 
were obtained on days 2, 4, 6, 9, 12, 14, 16, and 20 or at 
the time of death. Blood samples for viral isolation were 
taken from the cephalic or the jugular vein, One ml of 
blood was added to 2 ml of antibiotic "cleaninq fluid" 
(described later) for this purpose, 
For serum-virus-neutralization (SVN) tests, blood was 
withdrawn from the jugular vein bRfore inoculation and on 
days 7, 14, 21, and 28, After standing at 4 C overnight the 
blood was centrifuged at 275 x g to separate the serum from 
the clot. The serum was removed and stored at -20 C until 
it was used in the SVN test, 
~ I 
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Antibiotic "Cleaning Fluid'' 
For the primary isolation of viruses, all specimens 
were suspended in 2 ml of cleaning fluid prepared in 
the following manner: 
For 600 ml of cleaning fluid: 
585 ml BME containing D.11 percent NaHC03 
600,000 units crystalline penicillin and 
600, ODO ,.ug dihydrostreptomycin in 
3 ml of distilled water 
12,000.ftlg Fungizone in 12 ml of distilled 
water 
The final concentration of antibiotics was 1,000 units 
of penicillin, 1,DDD,iug/ml of streptomycin, and 20.Ng/ml 
of Fungi zone; 
Viral Isolation 
After standing at room temperature in antibiotic 
''cleaning fluid" for 2 hours those specimens that contained 
a large amount of particulate material were cleared by 
centrifuging at 115 x g for 10 minutes. Blood sampl~s, 
, like other specimens, were placed in 2 ml of viral cleaning 
fluid, frozen in liquid nitrogen, and thawed to disrupt· 
the red blood cells. Medium from tubes containing 4-day-old 
MOCK cell cultures was poured off and D.25 ml of the speci-
men was pipetted into each of 2 tubes, The specimens were 
allowed to ;adsorb at room temperature for 2 hours. Each 
tube was rinsed with 1.D ml of maintenance medium~ One ml 
. I 
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of maintenance medium was then added and the specimens were 
incubated at 37 C. Each tube was examined every other day 
for the presence of CPE. When 75 percent of the mono-
layer of cells showed CPE, the specimens were stored at 
4 c.for subsequent viral identification. 
Viral Identification 
The first and last viral isolation from each site 
sampled, i.e. the nasal cavity, was identified by a tube 
serum-virus-neutralization test. Four tubes containing 
4-day-old mDCK cell cultures were used to identify each 
isolate. The tubes were inoculated and virus adsorbed 
as previously described for viral isolations. Two of 
the four tubes from each isolation received maintenance 
medium containing 10 percent anti-CHV rabbit serum 
whereas the other two tubes received maintenance medium 
containing 10 percent normal rabbit serum. Each tube 
was examined daily for evidence of CPE. Positive CHV 
identification was made on the basis of partial or com-
plete neutralization by the positive CHV antiserum. 
' / 
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M-96 Mycoplasma Medium 
.M-96 ··mycoplasma medium was used for the propagation of 
all mycoplasmas. The formulation of this medium is ·as follows: 
{Dr. m, Frey, Unpublished data. Veterinary Medical Research 
Institute, Iowa State University, Ames, Iowa.) 
Peptone csa 
Peptone Ba 
Peptone Ga 
Yeast autolysatea 
Yeast extracta 
Na Cl 
K Cl 
Mg SD4·7H20 
Cata lase 
Hepes buffer 
L-arginine H Cl 
L-glutamine 
DNA* 
Eagle'~ MEM vitamin solution 
1 OOx 
Cholesterol emulsion** 
Glycerol 
Per liter· 
4.0 g 
2. 0 g 
2.0 g 
2. 0 g 
2.0 g 
5.0 g 
0.4 g 
0.2 g 
0. 001 g 
3.5 g 
o. 06 g 
0.09 g 
0.02 g 
1 o ;u ml 
2.0 ml 
0.15 ml 
apfizer Diagnostics, Chicago, Illinois. 
binternational Scientific Industries, Cary, Illinois. 
*Two ml of a 1 percent solution of DNA (not highly 
polymerized) in water buffered to pH 7.2. 
**Cholesterol emulsion (Method of Edward and Fitzgerald) 
(43): Two hundred mg of cholesterol was put in a sterile 
petri dish and dissolved in diethyl ether~ The ether was 
allowed to evaporate and the process was repeated. 
The sterile, recrystallized cholesterol was dissolved 
in 6-8 ~l warm 95 percent ethyl alcohol. 
The alcohol solution was drawn into a prewarmed glass 
Luer-lock syringe fitted with an 18 or 20 gauge needle. 
Two hundred ml of distilled, deionized water was boiled 
to drive off the absorbed CD2. The water was then cooled to 
90 C and the cholesterol was injected beneath the surface of 
the water. 
' ' 
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The solid components were dissolved in 400 ml of water 
and the liquid components were added to this solution, Water 
was added to bring the_ volume to 500 ml, To prepare IYl-96 
''. 
liquid medium an equal volume of water was added to the 
above solution. To prepare IYl-96 agar a double concentration 
of molten agar1 (1.5 percent) was added to 500 ml of double-
strength IYl-96 liquid medium, The IYl-96 liquid mycoplasma 
medium was supplemented with 10 percent heat-inactivated 
(56 C ~or 30 minutes) rabbit serum. For the primary isolation 
of mycoplasmas, 1,000,000.units/liter of penicillin and 
5 g/lit-er of thallium acetate were added to inhibit the 
growth of _all ba_cteria except for the mycoplasmas, IYl-96 
mycoplasma agar was also supplemented with 10 percent heat-
inactivated rabbit serum, 
IYlycoplasmal "Cleaning Fluid" 
Equal volumes of specimen, suspended in antibiotic 
"cleaning fluid", and mycoplasmal "cleaning fluid" were 
mixed and allowed to stand at room temperature for 90 
minutes before being used as inoculum. To prepare the 
mycoplasma "cleaning fluid" 500,000 units of penicillin 
and 200 mg of thallium acetate were added to 100 ml of 
sterile water. 
1Difco Laboratories, Inc., Detroit, Michigan, 
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Isolation of Mycoplasma 
After standing at room temperature for 90 minutes 
0.5 ml of each mycoplas~a specimen was added to 4.5 ml 
of mycoplasma medium containing 2 mg thallium acetate and 
1,000 units of penicillin. After 48 hours incubation at 
37 C, 0.5 ml of each culture was transferred to 4.5 
ml of uninhibited mycoplasma medium~ This step was repeated 
after another 48 hours. Cultures that showed evidence of 
mycoplasmal growth such as turbidity when the contents 
of the tube was swirled, were inoculated ontfr mycriplasma 
agar plates. One drop of the culture was placed on the 
agar.and the plate was tilted to allow the inoculum to 
spread. The plates were incubated at 37 C in a CD2 incuba-
tor containing 5 percent CD2 until the mycoplasma cglonies 
appeared, which was usually after 48 hours, Mycoplasma 
colonies were identified by their typical "fried egg" 
appearance when observed under low power magnification. 
Bacteriological Media 
' Tryptose blood agar 
Tryptose blood agar base with 5 percent citrated bovine 
blood and 1,8 percent agar with 1 percent proteose-peptone 
#3 added was used in the isolation and identification of 
~. bronchiseptica, 
MacConkey's agar 
MacConkey•s agar fortified with 1 percent dextrose was 
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also used in the isolation and identification of Q, bronchi~ 
septica, 
Sugar ~ media 
Sugar base media used in the isolation and identifica-
tion of ~. bronchiseptica contained 0,5 percent of the 
dextrose or lactose in tryptose broth. The formula for the 
tryptose broth used is as follows: 
Bacto-Seef eitract1 
Bacto-Yeast extract1 
Tryptose 
Na Cl 
Andrades indicator 
Ula ter 
Andrades indicator 
a. 5. 
3.0 g 
3,0 g 
15,0 g 
5.0 g 
10, 0 ml 
1 • 0 liter 
. ·.,.,. 
Andrades indicator used in the sugar base media was 
formulated as follows: 
Acid fuchsin 
NaOH (1N) 
Water 
0,5 g 
16.0 ml 
a. s. 100,0 ml 
The ingredients are combined and allowed to stand for 10 
days after which the solution is filtered. 
Litmus milk 
y·, 
Litmus milk was used in the identification of Q. !ll:ruJ.-
chiseotica, The litmus milk was prepared as follows: 
Bacto-litmus1 
Bacto-skim milk powder1 
Distilled water 
0,15 g 
30,0 g 
a. 5. 300,0 ml 
1Difco Laboratories, Inc,, Detroit, ~ichigan, 
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The litmus milk was dispensed into tubes with cotton 
stoppers so that the characteristic blue ring formed during 
the alkalinization process. 
Bacterial Isolation and Identification 
Bordetella bronchisebtica was of primary concern as 
a resident bacterium in the experimental dogs because it 
has been incriminated as a prima.ry and secondary etiological 
agent in canine respiratory disease, Colonies suspected of 
being g, bronchiseptica (on the modified MacConkey's agar 
plates) were selected and inoculated into tryptose broth, 
After 24 hours incubation a drop of this culture was heat 
fixed on a glass slide and stained with Gram's stain, Any 
cultures that were gram-negative pleomorphic rods showinq 
coccoid or bacillary forms ranging from 0,5 to 1.S)Jm were 
examined further by inoculating differentiating media. 
To make positive identification the suspected cultures 
were inoculated into litmus milk, Simmons' citrate aqar1, 
glucose broth, lactose broth, and urea broth, 1 g, bronchi~­
~ cultures hydrolyze urea within 12 to 24 hours of incu-
bation. Citrate is utilized uJi thin 1 to 2 days, and li. tmus 
milk and dextrose are alkalinized slowly, Lactose is not 
utilized by g, bronchiseptica. 
1 Di~co Laboratories, Inc., Detroit, Michigan, 
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Ex perimenta 1 Dogs 
Dogs used in experiments 1 through 4 were 6-month-old 
Beagle dogs bred and raised in the closed dog colony of 
the Veterinary reedical Research Institute (VMRI) at Iowa 
State University, The dogs used in experiment 6 were 16-
week-old Beagle dogs that were also obtained from the VMRI 
colony. Ten-week-old Beagle dogs obtained from a commercial 
dog breeder were used for experi~ent 7. Beagle dogs were 
obtained from both the vmRI colony and a commercial dog 
breeder for experiment 5. Dogs 19 through 26 and dogs 29, 
30, and 32 were obtained from the VMRI colony at 16 weeks of 
age for experiment 5, while dogs 27, 28, 31, 33, ·and 34 were 
obtained from the commerical colony at 12 weeks of age. The 
4 dogs used in experiment 8 were 12-week-old mixed breed 
dogs from a litter of pups raised on a local farm. 
Preinoculation Examination 
All dogs were examined for signs of disease prior to 
experimentation. The pharyngeal area, nasal cavity, con-
junctiva! sac, and vagina or penis of each dog was swabbed 
with a cotton swab. Each swab was placed in 1 ml tryptose 
broth and used for inoculation of bilood agar and IY!acConkey 1 s 
agar for isolation of~· bronchiseptica. Of the remaining 
specimen 0,25 ml was added to 0,25 ml mycoolasma "cleaning 
fluid" and 0,25 ml was added to 2 ml antibiotic "cleaning 
fluid" for mycoplasma and virus isolation respectively, 
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Histological Procedures 
Tissues collected at necropsy were fixed in 10.percent 
buffered formalin for 4 days, Sections of nasal turbinate 
and ribs were decalcified using Decal1 for 12 hours then 
washed in running tap water for 6 hqurs, All tissues were 
dehydrated in graded ethanol solutions, cleared in xylene, 
and embedded in paraffin~ Sections were cut at 6~m and 
mounted with Permoun~2 mounting medium on glass slides, 
All sections were stained with Harris 1 s hematoxylin and 
eosin Y (Hand E). These procedures were carried out 
as described in the Armed Forcas Institute of Pathology's 
Manual of Histology and Special Staining Techniques (74), 
1Scientific Products Division, Hospital Supply Corp,, 
Evanston, Illinois. 
2Fisher Scientific Company, Fair Lawn, New Jersey, 
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EXPERIMENTAL PROCEDURES AND RESULTS 
Laboratory Comparison of CHV-270 and CHV F-205 
The results from cross SVN tests using CHV strain F-205 
and CHV-270 viruses and CHV-270 rabbit antiserum and CHV strain 
F-205 antiserum1 are listed in Table 1. The antiserum dilu-
tions which neutralized CHV F-205 were identical while the 
antiserum diluti~n which neutralized CHV-270 was greater for 
CHV-270 th~n it was for CHV F-205 but the difference was not 
significant. 
Table 1. Cross serum-virus-neutralization tests between 
CHV-270 and CHV F-205 
Virus 
CHV F-205 
CHV-270 I 
Antiserum 
CHV-270 CHV F-205 
54a 
aAntibody titers are expressed as the reciprocal of the 
highest dilution of antiserum that caused ~ 50 percent re-
duction in plaques in comparison to controls, 
Microscopic examination of MOCK cell cultures infected 
with CHV strain F-205 or CHV-270 and stained with hema-
toxylin-phloxin-safran or with H and E revealed similar 
CPE. The affected cells in both infections were rounded 
and clumping of the nuclear chromatin was observed, Intra-
nuclear inclusion bodies that developed in MOCK cells 
10btained from Dr, L. E. Carmichael, Cornell University, 
Ithaca, New York. 
l 
' \ 
. I 
I 
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infected with CHU F-205 were similar in number and in morph-
ology to inclusions observed in MDCK cells infected with 
CHU-270. The inclusion b~dies were eosinophilic and varied 
in size, sometimes completely filling the nucleus. 
• 
The sensitivity of MDCK cells and DKC to infection 
with CHU-270 and CHU strain F-205 was determin~d. Neither 
cell type was significantly more sensitive to either virus. 
Due to the ease of working with the MDCK cells in.the 
laboratory, they were used throughout these experiments ~s 
the laboratory host system. 
Adenovirus A26/61 Antibodies in CHU-Infected Dogs 
Antibody titers to adenovi~us A26/61 were determined 
by the SUN plaque-reduction method. The antibody ti tars to 
adenovirus A26/61 of several dogs infected with CHU-270 
are listed in Table 2. 
Table 2. Adenovirus A26/61 antibody titers of selected dogs 
Dog No. Experiment No. Day Sampled Titera 
14 4 28 <2 
23 5 56 <2 
25 5 56 <2 
27 5 56 <2 
42 7 7 <2 
43 7 7 <2 
•Antibody titers in this table and all subsequent tables 
are expressed as the recip~ocal of the highest dilution of 
antiserum that caused a SD percent reduction i~ plaques in 
comparison to controls, · 
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Results of Preinocula tion Exa mina t i ons 
Doqs in a ll experime n ts wer e found t o be healthy and a ll 
ha d tem peratures between 37 . 8 and 39 . 2 C ( 1 00-1 02 . 5 F ) . No 
viruses wer e iso late d from these doqs dur i n q the pr ein oculation 
examina t i ons. Man y mycopla s ma s wer P. i so late d fr om t he var ious 
sites sampl e d as indicate d in Ta b le 3 . Ror de tel l a br onchisep-
ti ca wa s i so la ted fr om several doqs a s ind icated i n Ta ble 4 , 
however , there wa s n o correlati on be twP.e n the is o l a ti on of~ . 
bronc h i sept i ca and t he incidence of clinical symptoms . 
The ubiqu i ty o f my c oplasmas in docs anrl the fact t hat no 
mycop lasma pathoqe ns ha ve been i denti f ierl for doos make s i t 
d iff icult to eva lua te the i mpor t ance of thei r isola t ion . In 
this s t udy the myc op la s ma s were consider e d a s par t o f the 
normal microflora of t he doq . 
Experiment 1: 
Pathogen i ci ty of CH V in Do gs I noc u late d I ntranas a l l y 
The pur pose of this experiment wa s t o t est t he pa thoqe ni -
c ity of CHV - 27 0 when inoculated i ntr a na s ally int o doos . Dnas 
5 , 6 , 7 and 8 recei ved 5 . 3 x 1 05 pf u of CH V- 27 0 , 0 . 5 ml in 
ea ch nari s , wh ile doqs 1 , 2 , 3 , and 4 r e ce i ved 1 . S ml o f MOCK 
cell- culture fluid in each nari s on da y z ero . Blood , pha rvn-
gea l , nasal and qe ni ta l specimens were oh t ai nP.rl on rla ys 2, 4 , 
6 , 9 , 12 , and 16 f or vi r us i solati on . Coni un c tiva l sa mo l es 
were obta i ned on da ys 9 , 12 , and 1 ~ on l y . Rlood s am ple s for 
hemat o l oqy were obt a i ned on days 2, 4, 6 , 9 and 12 , a nd b lood 
samples for se ro l og i cal tests wer e ob taine d on days z e r o a nd 
45 
Table 3. Resu 1 ts of preinoculation examinations 
mental dogs for mycop las mas 
Dog No. Oral Nasal Genital 
Experiment 1 1 +a + + 
2 + ac 0 
3 + 0 0 
4 + 0 + 
5 + 0 0 
6 + 0 0 
7 + 0 0 
8 + 0 0 
Experiment 2 Used control dogs of experiment 
1 ' 2, 3, and 4. 
Experiment 3 Used control dog of experiment 
Experiment 4 14 + 0 
15 + 0 
16 + 0 
17 + + 
18 + 0 
aPositive isolation of mycopla~ma, 
bNot Done, 
cNo mycoplasma isolated, 
0 
0 
0 
0 
0 
of ex per i-
Conjunctival 
N .D. b 
N .D. 
N.D. 
N.D. 
N .D. 
N.D. 
N.D. 
N .D. 
1 ' dog ii 
2, dog ff3. 
0 
0 
0 
0 
0 
4G 
Table 3. Continued 
Dog No. Oral Nasal Genital Conjunctiva! 
Experiment 5 19 + 0 0 0 
20 0 a 0 0 
21 a a 0 a 
22 0 a a 0 
23 + + 0 0 
24 + 0 0 0 
25 + 0 0 a 
26 + + + a 
27 + + + + 
28 a + + + 
29 + + a + 
30 + + a 0 
31 + + a + 
32 a 0 a a 
33 + 0 a a 
34 + a a 0 
E:x per:iment 6 35 + 0 a a 
36 + ·O 0 a 
37 a a a a 
38 + 0 0 a 
39 + a 0 0 
40 + 0 0 0 
' ' ,J 
47 1 
I 
Tabie 3, Continued 
Dog No. Oral Nasal Genital Conjunctiva! 
Experiment 7 41 + 0 0 0 
42 + + 0 0 
43 + 0 0 + 
44 + 0 0 0 
45 + + 0 0 
46 + 0 0 0 
47 0 + 0 0 
48 + + 0 + 
Experiment 8 49 + + 0 0 
50 . 0 + 0 D 
51 D + D D 
52 D D D 0 
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Table 4, Results of preinoculation examinations of experi-
mental dogs for Bordetella bronchiseptica 
Dog No, Experiment No, Pharynx Nasal cavity 
2 1 oa +b 
4 1 0 + 
27 5 0 + 
28 5 0 + 
29 5 0 + 
30 5 0 + 
31 5 0 + 
35 6 + 0 
37 5 + 0 
41 6. 0 +· 
43 7 0 + 
45 7 0 + 
47 7 + 0 
aNo .§.. bronchise ptica isolated, 
bPositive isolation of .§.. bronchise ptica, 
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28. 
Results of virus isolation are recorded in Table s. Virus 
w~s isolated for 9 days from the inf~cted dogs, The isolations 
from the genital tract and from the conjunctiva indicated that 
the virus spread to these sites, No viremia was detected as 
indicated by the lack of viral isolations from the blood spec-
imens, however, the samolinq interval may have been too great 
to detect a viremia. All 8 do9s had negative antibo'dy tit.ers 
before inoculation as indicated in Table 6. The control doqs 
remained negative and the dogs that were infected developed 
antibody titers of 321 to 64. 
The results of the hematologic tests, recorded in Table 
7, revealed few changes from the normal. The packed cell vol-
ume, white blood cell count, red blood cell count and the hemo-
globin content all remained within normal ranges (96) except 
for 3 RBC counts that dropoed slightly below the normal range. 
The clinical sions, which are recorded in Table 8, were 
primaril~ associated with the eyes, Excessive lacrimation 
and conjunctivitis were often accompanied by an accumulation 
of serous exudate at the medial canthus of the eye. Dog 
number 2 was observed sneezing nn day 2 postinoculation, The 
temperature of all doqs remained within normal limits through-
out the 28-day experiment. 
1All antibody titers in this and all subsequent experi-
ments are expressed as the reciprocal of the highest dilution 
of antiserum that caused a SD percent reduction in plaques in 
comparison to the controls. 
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Table 5. Experiment 1: CHV reisolated from dogs after intra-
nasal inoculation of CHV-270 
Days sam[11ed 
Dog No, 2 4 6 ga 12 16 
5 Nb NP NP NP DC 0 
6 NPG NP NP 0 0 0 
7 NPG NPG NPG NPC 0 0 
8 NP NP NPG NPC 0 0 
aconjunctival sac swabbed only on days 9, 12 and 16. 
bN, P, G and C represent positive CHV isolations from 
the nasal eavity, pharynx, genital tract and conjunctival 
sac, respectively. 
CNo. CHV isolated, 
Table 6. Experiment 1: CHV antibody titers of dogs after 
intranasal iMoc~lation of CHV-270 
Antibody titers 
Dog No~ Day 0 Day 28 
1 <2 <2 
2 <2 <2 
3 <2 <2 
4 <2 <2 
5 <2 64 
6 <2 64 
7 <2 64 
8 <2 32 
aDogs #1, 2, 3 and 4 =uninfected control dogs. 
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Table 7. Experiment 1: Blood parameters of dogs after intra-
nasal inoculation of CHV-270 
Blood Qarameters 
Day 
w scb RBCb 
Hemoglobin 
Dog No, Sampled PCV8 (mg %) 
1 2 49 10,700 6.2 16;9 
2 2 44 10,600 6,2 15.6 
3 2 44 15,500 5,B 15,6 
4 2 43 12,300 5.9 15. 2 
5 2 so 10'900 6,5 16.4 
6 2 39 6,300 5.4 13~6 
7 2 41 B,900 5,1 13.6 
8 2 43 15,300 5,9 14,0 
1 4 46 12,200 6,0 16 .1 
2 4 46 16,600 5,6 15.2 
3 4 45 10'400 5,6 14.8 
4 4 47 12,200 8.2 15 ,6 
5 4 45 12, 6 00 6.5 14. 8 
6 4 47 12,200 6,8 15 .2 
7 4 45 9,400 s.a 15.6 
8 4 45 11,900 7.2 15,6 
apacked cell 
blood volume, 
volume reported as percentage of total 
blJlhite blogd cell count reported per ml and red blood 
cell count x 10 per ml. · 
I, • • • 
52 
.Table 7. Continued 
Blood Parameters 
Day 
PCV8 wscb RB Cb 
Hemoglobin 
Dog No. Sampled (ing ~) 
1 6 47 13,300 5.9 15 .2 
2 6 39 17, ODO 6.6 18. 0 
3 6 42 7,000 5.3 15 .2 
4 6 42 10,800 6.1 . 14. 0 
I 
5 6 49 8,300 6.8 15.6 
6 6 42 10,700 6.3 14.4 
7 6 40 12,300 5.9 13.6 
8 6 45 10,6 DO 6.8 15 .6 
1 9 45 15, 7 DO 6.7 17.4 
2 9 45 13,600 6.3 15.6 
3 9 42 1 0, 1 OD 6.1 15,6 
4 9 41 16, 1 00 6.1 14.8 
1 12 42 13,600 6.2 18.9 
2 12 45 14,900 6.3 16 .1 
3 12 40 11,200 6.0 16.1 
4 12 39 17,100 5,6 14.4 
/ 
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Table 8, Experiment 1 : Clinical s iqns elicited in dogs 
inoculated intranasally with CHV-270 
Day Lacri- Conjuncti- Sneezing Other 
Dog No, Sampled ma ti on vi tis Clinical 
signs 
6 2 +a. ob + enlarged 
tons f ls 
8 2 + 0 0 
6 4 + 0 0 
8 4 + 0 0 
5 6 0 + 0 
8 6 0 + 0 
6 8 0 + 0 
7 g 0 +· 0 
6 12 + 0 0 
aClinical sign present. 
bClinical sign absent. 
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Experiment 2: 
Pathogenicity of the CHV for the External 
Genitalia of Male Doqs 
Dogs 9, 10 and 11 were inoculated iritrapreputially 
with 5,1 x 105 pfu of CHV-270, The control dog, number 12, 
received 1 ml of MOCK cell-culture fluid by the same route 
of inoculation, Blood, pharyngeal, nasal, genital and 
conjunctival specimens were obtained on-days 2, 4, 6, 9, 
12, 16, 20 and 28, The results of viral isolations are 
recorded in Table 9, The virus spread to the nasal cavity, 
the pharynx, and the conjunctiva, but no viremia could be 
demonstrated. Virus was isolated from the genital tract 
for only 6 days, but from the nasal cavity and the conjunc-
tiva for up to 20 days postinoculation. 
Table 9, Experiment 2: CHV reisolated from dogs after 
intrapreputial inoculation of CHV-270 
Dai::s sam[;:!led 
Dog No, 2 4 6 9 12 16 20 
9 Ga G ob c N 0 0 
10 G G NC N 0 PC 0 
11 G G NGC c PN NC NC 
12 (control) 0 0 0 0 0 0 0 
aG 
' N and C reoresent positive CHV isolations from the sheath, nasal cavity and conjunctival sac respectively, 
bNo CHV isolated. 
coog g was euthanized for· the purpose of a postmortem 
examination on day 20. 
28 
c 
0 
0 
0 
Dog g was euthanized on day 20 for the purpose of a 
postmortem examination. Virus isolation was attempted from 
penis mucosa, epididymis, testicle, bulbus glandis, pro~tate, 
urethra, bladder, kidney, tonsil, lung and trachea. No 
virus was isolated from any of the above-mentio~ed tissues. 
No gross lesions were seen and no microscopic lesions pre-
sent in sections prepared from the penis mucosa, urethra, 
epididymis, prostate, kidney, testicle, trachea, heart, 
liver and lung. 
Blood samples ·for serological tests were obtained on 
~day ze"ro and day 28. All dogs had negative titers to CHV 
before inoculation and the control dog, number 12, remained 
negative until day 20 at which time this dog was removed 
from this experiment so that it could be used in experiment 
3. The serological results are recorded in Table 10, 
Table 10. Experiment 2: CHV antibody titers in male doo~ 
after intrapreputial inoculation of CHV-270 · 
Da~s sami;!led 
Dog No. 0 14 20 28 
g <2 2 N.D. a ---b 
10 <2 N.D. N.D. 8 
11 <2 N.D. N.D. 16 
12 (control) <2 N .D. <2c N.D. 
aNot done, 
bDog number g was killed and necropsied on day 16. 
CDog number 12 was used in experiment 3 on day 20. 
5(i 
On day 4 the mucosa over the base of the penis and the 
preputial reflection of doq 9 and dog 10 became reddened 
and had a roughened granular appearance. The hair at 
the orifice of the sheath became wet and the doqs licked 
excessively at the orifice of the sheath. A similar 
condition appeared in doq 11 on day 5. All of these 
lesions on the penis regressed in 2 or 3 days. No vesicles 
were ever observed on the penis mucosa, however small 
vesicles cuuld have been overlooked as it is difficult 
to examine the entire penis mucosa of a dog, On day 9 
dogs 9 and 11 developed a·conjunctivitis which regressed 
in 2 days. 
Experiment 3: 
Acute CHV Genital Infection of a Male Doo 
Dog 13 was inoculated intrapraputially with 1 ml of 
fluid containing 7.6 x 105 pfu of CHV-270. Four days after 
inoculation the doq was euthanized with an overdose of pheno-
barbital and a postmortem examination was performed. 
Petechial hemorrhages were seen in the penis mucosa. There 
were also clear raised areas on the penis mucosa that 
measured approximately 1 mm in diameter. H and E sections 
of the penis mucosa revealed that these raised areas were 
foci of lymphoid infiltration which can be seen in Fiqure 1. 
H and E stained sections of testicle, bulbus glandis, 
epididymis, urethra, luno 1 liver, kidney, trachea and spleen 
showed no histological c~anges. 
I 
I 
Figure 1. 
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Lymphoid nodule in thP. penis mucosa of a dog 
4 days after intrapreputial inoculation with 
CHV-270. H and E x 180 
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Virus isolation was attempted from the above-mentioned 
tissues as well as bladder, tonsil, nasal swabs, pharyngeal 
swabs, and genital swabs. CHU was only isolated from the 
pharyngeal and genital swabs and from the tonsil. 
Experiment 4: 
Pathogenicity of CHU for the 
Genitalia of Female Dogs 
One ml of a viral suspension containing 5.0 x 105 pfu 
of CHV-270 was inoculated into the vagina of dogs 14, 15, 
16 and 17. Dog 18 received 1 ml of IYIDCK cell-culture 
also intravaginally. Specimens for virus isolation were 
obtained on days 2, 4, 6, 9, 12, 16 and 20 and blood for 
seroloqic tests was collected on days zero and 28. As in 
previous experiments the infected dogs developed neutralizing 
antibodies to CHV-270 while the control remained negative 
(Table 12). It can be seen from Table 11 that the virus 
did replicate in the vaqina as CHU was isolated from the 
vagina for 6 days postinoculation. However, it did not 
spread much as the virus was only isolated from one sits 
other than the genital tract, that site being the conjunctiva 
of dog 14. 
The lesions that were produced in the vagina of the 
CHV-270 infected dogs were quite dramatic (Table 13). Two 
days after inoculation all doqs developed a severe vaginitis 
and dog 14 had a slight purulent vaginal discharge. Several 1 
mm glistening white raised areas were present.in the vaginal 
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Table 11, Experiment 4: CHV reisolated from dogs after 
intravaginal inoculation of CHV-270 
Da)1S sam(:!led 
Dog No, 2 4 5 g 12 15. 20 
14 Ga G GC c ob 0 0 
15 G G G 0 0 0 0 
15 G G G 0 0 0 0 
17 G G G 0 0 0 0 
i8 (control) 0 0 0 0 0 0 0 
aG and C represent positive CHV isolations from the 
vagina and conjunctiva! sac, respectively. 
bNo CHV isolated, 
Table 12. Experiment 4: CHV antibody titers in dogs after 
intravaginal inoculation of CHV-270 
Da)1S sam(:!led 
Dog No, 0 28 
14 <2 32 
15 <2 8 
15 <2 8 
17 <2 16 
18 (control) <2 <2 
-1 
I 
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Table 13, Experiment 4: Clinical signs elicited in dogs 
inoculated intra.vaginally with CHV-270 
Vaginal les ion1i. 
Petechial 
or 
Dog Lymphoid submucosal 
No, Day Vaginitis nodules hemorrhages Conjunctivitis 
14 2-5 +a + + ob 
15 2-5 + + + 0 
16 2-5 + + + 0 
17 2-5 ·+ + + 0 
17 5 0 0 0 0 
14 6 + 0 0 0 
15 6 0 0 + 0 
16 6 0 0 + 0 
17 6 + 0 + 0 
16 7 0 0 0 + 
14 9 0 0 0 + 
16 9 0 0 0 + 
14 12 0 0 0 + 
16 12 0 0 0 + 
14 16 0 0 0 + 
16 16 0 0 0 + 
8 Clinical siqn present. 
bClinical siqn absent. 
) 
/. 
.·-·. 
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muqosa of each dog. These white areas appeared as· vesicles 
but examination of H and E sections of these affected areas 
of vaginal mucosa revealed that they were lymphoid nodules 
(See Figure 4). The vaginal mucosa also contained many 
petechial and submucosal hemorrhages. The majority of 
the lesions were on the dorsal and l~teral aspects of the 
vestibule. A dry crusty lesion also appeared in infected 
dogs at the dorsal commissure of the vulva right at the 
mucocutaneous junction. On day 5 1 dog 17 had a yellowish 
vaginal exudate which lasted for 2 ·days. A staphylococcus 
and a streptococcus were isolated from this exudate, but CHV 
was also isolated from the vagina of this dog on day 6. 
The vaginal lesions were r.egressing by day 6 and were 
completely gone by day 7. 
The only other symptom seen in these dogs was conjunc-
tivitis that developed in dogs 14 and 16 on day 7. This 
condition lasted for about 10 days. 
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Ex per.iment '5:: 
•P.r-otet:tion · Prov.ided by GHV.-33 .when· -lAtlniin:is-.Tiwad ·by 
j)Jff'f.-aTartt Routes of :Inoculation ,0111d Cfrha!lllenged 
iI1't:lrrava ginall'l y .111Hth ffi-HIJ_..;p7 0 
This ex per.iment was des.igned ·to_ ,test tt-he 1.v.irulence 
and .immunogenicity of CHV.-33.. Dogs 119,, .2Q, ·z.1 anrl 22 were 
controls and did ·not.receive anything on day Q, Dogs 23, 
24, 25 and '26 were .inoculated intravaginally .with 1 ml of 
CHV-33 containing 5 .• O x 1 o5 pfu of '.virus.. Dogs 27., 2fl, 
33 and 34 were .inoculated intranasal:ly .with ·the same 
amount of CHV.-·33 and dogs 29., 30., 3'1 and 3·2 .were inoculated 
subcutaneousl~, also with 5,0.x 105 pfu of CHV-33, Each 
group of 4 ·dogs was maintained in icsol>ation ·cages (2 dogs 
per cage) ·so ·that ·no -contact .. spread rcould. · accur ·between 
groups .• 
.:All ·sixteen dogs were challenged iintravagina'l:ly with 
5 .• 1 x ·105 pfu of CHV~270 on day 28 .• 'The :intravaginal route 
was chosen ·for challenging because 1the vagina was ·the only 
site .which responded in a recogni·zable .. manner ·to· CHV 1 DO 
percent of ·the time, Each dog was sampled on day 2, 4, 6, 
9, 12, 16 and 20 after both the °CHIJ.;.'33 inoculation and the 
CHV-270 ·challenge. 
The virus isolations, serologica'i results and clinical 
signs from this experiment are recorded in Tables 14, 15 
and 16., .respectively. When .inoculated :int-ranasally or 
subcutaneously CHV-33 caused an antibody response but when 
inoculated intravaginaily no antibody,response occurred, 
: I 
I 
' ., 
I 
' 
" 
Table 14. Experiment 5: CHV reisolated from doqs inoculated by various routes with 
CHV-33 and then challenged intravaqinally with CHV-270 
Route of Days samgled 
Dog CHV-33 · CHV-270 
No. Inoculation 2 4 6 9 12 16 20 challenge 30 32 34 37 40 44 48 
on day. _28 
19 0 0 0 0 0 0 0 Ga G PNGC c N N 0 
2 0 0 J 0 0 0 0 0 G GC c c c c· 0 
Control 
21 0 0 0 0 0 0 0 G GC PGC c NC N 0 
22 0 0 0 0 0 0 0 c c NG 0 PN N 0 
23 0 G G 0 0 0 0 c 0 0 0 0 0 0 
·'7'1 
24 G G G 0 0 0 0 G G 0 0 0 0 0 (.,> 
Intravaginal 
25 0 G G 0 0 0 0 c 0 0 0 0 0 0 
?' 0 0 n 0 0 0 n G G 0 0 0 0 0 _b u u 
27 PN N N 0 0 0 0 G G 0 0 0 0 
28 N N N p p 0 0 G G 0 0 0 0 0 
Intranasal 
33 Pl1J G 0 0 0 0 0 0 0 0 0 0 0 0 
34 i'JC PNC PN N 0 0 0 G 0 0 0 0 0 0 
aG i~ ' P and c represent positive CHV isolations from the ge ni ta 1, nasa·l ' cavity, pharynx and canjunctival sac, respectively. 
Table 14. Continued 
Route of Da~s sam[:!led 
Doo CHli-33 CHV-270 
No. Inoculation 2 4 6 9 12 16 20 challenge 30 32 :-14 37 40 44 48 
on day 28 
29 PN N 0 0 0 0 0 G c G 0 0 0 0 
3Q N N 0 N 0 0 0 0 0 G 0 0 0 0 
Subcutaneous 
31 l~C PNC PC p 0 0 0 G G 0 0 0 0 0 
32 0 0 0 0 0 0 0 G G G 0 0 0 0 
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Table 1 5. Experiment 5: CHV antibody titers of dogs iriocu-
lated by various routes and then challenged 
intravagina lly with CHV-270 on day 28 
Route of Antibod>'. titers 
Doq No, Inoculation Day 0 Day 28 Day 56 
19 <2 <2 64 
20 <2 <2 32 
Control 
21 <2 <2 Hi 
22 <2 <2 16 
23 <2 <2 16 
24 <2 <2 16 
Intravaginal 
25 <2 <2 16 
26 <2 <2 32 
27 <2 4 N .D. a 
28 <2 16 r~ .D. 
Intranasal 
33 <2 16 N.D. 
34 < 2 16 N .D. 
29 <2 16 N .D. 
30 <. 2 
Subcutaneous 
1 fl N .D. 
31 < 2 Hi N ,D. 
32 < 2 16 N.D. 
aNot done. 
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Table 16. Experiment 5:. Clinical signs elicited in dogs 
inoculated by various rnutes with CHV-33 and then 
challengeij intravaginally with CHV-270 on day 28 
Dog 
No. 
25 
27 
23 
24 
25 
27 
31 
34 
23 
24 
25 
26 
31 
33 
34 
Day 
2 
2 
3 
3 
3 
3 
3 
3 
4 
4 
4 
4 
4 
4 
4 
Vagina 1 lesions 
Petechia 1 or 
Lymphoid submucosal 
Vaginitis nodules hemorrhages 
0 
+ 
+ 
+ 
0 
0 
0 
+ 
+ 
+ 
+ 
0 
+ 
0 
b 0 
0 
0 
0 
0 
0 
0 
0 
0 
+ 
0 
+ 
0 
0 
0 
+ 
0 
+ 
+ 
+ 
0 
0 
0 
+ 
+ 
+ 
0 
0 
0 
0 
aClinical siqn present. 
bClinical sign absent. 
Other· 
clinial 
signs 
lacrimation 
and 
rhinorrhea 
pulmonary 
congestion, 
rales 
conjunctivitis 
conjunctivitis 
severe 
conjunctivitis 
severe 
conjunctivitis 
67 
Table 16. Continued 
Vaginal lesions 
Petechia 1 or Other 
Doq Lymphoid submucosal C linica 1 
No. Day Vaqinitis nodules hemorrhages signs 
23 5 + + + 
24 5 + + + 
25 5 + + 0 
26 5 + 0 + 
31 5 0 0 0 conjunctivitis 
34 s 0 0 0 conjunctivitis 
23 6 + + + 
24 6 + + + 
25 6 + + + 
25 7 + 0 + 
19 30 + 0 + vaginal 
discharge 
20 30 + + + 
21 30 + 0 + 
22 30 + + 0 
30 30 + + + 
31 30 + 0 + 
19 31 + 0 Cl vaoinal 
discharrie 
20 31 + + 0 
21 31 + + 0 
22 31 + 0 + 
23 31 + + 0 
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Table 16. Continued 
Vaginal lesions 
Petechial or Other 
Dog Lymphoid submucosal clinical 
No. Day Vaginitis nodules hemorrhages signs 
19 32 + 0 0 
20 32 + 0 0 
21 32 + + 0 
22 32 + + 0 
23 32 + 0 0 
24 
25 32 s l:j.ght vaginal inflammation - r:io vesicles 
26 
1 9 33 + 0 0 
20 33. + 0 0 
21 33 + + 0 
22 33 + + 0 
23 
24 33 Slight vagina 1 25 inflammation - no vesicles 
26 
22 34 + + 0 
29 34 + + 0 vaginal 
discharqe 
30 34 + + 0 
32 34 + + 0 
29 37 + + 0 
32 37 + + '0 
·' 
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This is in contrast to the antibody response observed after 
intravaginal inoculation of CHV-270 in experiment 4 and 
after intravaginal challenge of the control dog in experiment 
5. The spread of virus after challenge with CHV-270 was 
considerably more than was noted in experiment 4 ~ith intra-
vaginal inoculation with CHV-270. Intravaqinal, intranasJ1 
and subcutaneous inoculation with CHV-33 seems to provide 
some protection at least as far as virus spread was con-
I 
earned. Only one of the 12 dogs inoculated by these.routes 
yielded virus from a site other than the vagina. 
In those dogs inoculated intravaginally with CHV-33, 
vaginal lesio~s like those described in experiment 4 devel-
oped (See Figures 2, 3, 4 and 5), After intravaginal 
challenge with CHV-270, these dogs again developed vaginitis 
but the l~sions were much less severe and only one dog 
developed lymphoid nodules (only 2 nodules noted). 
Virus was isolated from 2 or more sites in 3 of the 4 
dogs inoculated subcutaneously with CHV-33. This would 
indicate a spread of the virus by some other means than 
physical contact. In 2 of these 4 dogs a.severe conjunctivitis 
developed, On day 4 the conjunctivitis was so severe that 
the eyes were swollen shut. The conjunctivas of these dogs 
was bright red due to the inflammation and the dogs were 
very sensitive to any manipulation of the eyelids, CHV was 
isolated from the eyes of both of these dogs during the time 
they had the conjunctivitis, 
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figure 2. Vaginal mucosa of doq 30, 6 days after intra-
vaginal challenge with CHV-270. Note the 
lymphoid nodules 
rigure 3. Lymphoid nodules and petechial hemorrhaqes in the 
vaoinal mucosa of doq 30, 6 days after intra-
vaginal challenge with CHV-270 
Figure 4. 
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Lymphoid nodule in the vaginal mucosa of dog 30, 
6 days after intravaginal challenge with 
CHV-270. H and E x 72 
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Figure S. Lymphoid nodule in the vaginal mucosa of dog 30 , 
6 days after intravaqinal challenqe with 
CHV~270. H and E x 1AO . 
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Of the 12 dogs inoculated with CHV-33, 5 dogs (27, 28, ., 
31, 33 and 34) failed to show clinical signs while only 
dog 33 failed to yield virus when .challenged with CHV-270. 
Experiment 6: 
The Effect of Environmental Temperature on the 
Pathogenicity of CHV on Dons 
Inoculated Intranasally 
Three 16-week-old dogs were placed in an environmental 
chamber 1 in which the temperature was continually varied 
from 22 C (72 F) during the day (12 hours) to D C (32 F) 
during the night (12 hours), After a 5-day adjustment 
period, these dogs were inoculated intranasally with 0,5 ml 
of mDCK cell-culture fluid per naris. These dogs were 
observed twice a day for any clinical signs. All 3 dogs re-
mained normal and they did not develop any CHV antibody 
titer by day 28. 
Another group of three 16-week-old doqs was placed in 
this environmental chamber and again the temperature was 
varied from 22 C (72 F) to 0 C (32 F) on 12 hour cycles, After 
a 5-day adjustment period, these 3 dogs were inoculated 
intranasally with D.5 ml per naris of a viral suspension 
containing 5.1 x 105 pfu of CHV-270. 
As can .be seen from Table 17, dog 38 had a titer of 8 
on day zero. On day 28, this dog had a titer of 64 while 
doqs 39 and 40 had titers of 16. This preinoculation titer 
1cER-B10 Controlled Environment Room, Sherer-Gillett, 
Marshall, michigan. 
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in dog 38 did not prevent the CHV infection because as tan 
be seen from Table 18, virus was isolated from this dog for 
6 days. However, the symptoms were not as severe in this 
dog as they were in doqs 39 and 40, On day 2 postinocula-
tion dog 39 was sneezing and had a sliqht rhinorrhea. By 
the next day doqs 39 and 40 were sneezing violently and 
both had rhinorrhea. On day 4 all doqs were sneezing and 
when swabbing the nose a blood-tinged pink fluid was noted 
on the c~tton swabs, Dog 38 only sneezed for aoproximately 
one day but dogs 39 and 40 sneezed until day B. On day 5 
both of these dogs developed a conjunctivitis that also 
lasted until the 8th day postinoculation, 
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Table 17, Experiment 6: Antibody titers· after intranasal 
inoculation of CHV-270 in dogs maintained at 
varying environmental temperatures 
Dog No, Days sampled 
0 28 
35 (control) <2 <2 
36 (control) <2 <2 
37 (control) <2 <2 
38 8 64 
39 <2 16 
40 <2 16 
Table 18, Experiment 6: CHV reisolated from dogs inoculated 
intranasally and maintained at varying environ-
mental temperatures 
Days sampled 
Dog No, 2 4 6 g 12 
38 NPa NP N ob 0 
39 NP NP NC 0 0 
40 NPC NP NC c 0 
aN, P and C represent positive CHV isolations from the 
nasal cavity, pharynx and conjunctival sac, respectively. 
bNo CHV isolated, 
I 
I 
' 
\ 
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Experiment 7: 
Intranasal and Intraconjunctival Inoculation 
of CHV in Dogs Maintained at Normal and Varying 
Environmental Temperatures 
Eight 10-week-old dogs were divided into 2 groups of 
4 dogs each. One group was placed in an environmental 
chamber and the other group was placed in plastic isolation 
cages. The temperature in the environmental chamber was 
varied from 22 C (72 F) to 0 C (32 F) at 12 hour intervals. 
' After a 5~day adjustment period 2 dogs maintained in. the 
varying temperature (dogs 41 and 42) and 2 dogs (45 and 46) 
maintained at normal room temperature 22 C (72 F) were 
inoculated by injecting D.25 ml of a CHV-270 suspension 
containing 1.5 x 106 pfu/ml into the conjunctiva! sac of 
each eye. The other 2 dogs in each group, dogs 43, 44, 47 
and 48, were inoculated intranasally with 1.0 ml of suspen-
sion of CHV-270 containing 7,5 x 105 pfu/ml. 
Blood samples were obtained before inoculation and at 
7 day intervals for serological tests, Pharyngeal, nasal, 
genital, and conjunctival samples were obtained on days 
2, 4, 6, 9, 12, 16 and 20 for viral isolation. 
As can be seen in Table 20, all doos had preinoculation 
antibody titers to CHV, It was decided to proceed with the 
experiment using these doqs because the positive preinocula-
tion titers'would add an interesting dimension to this 
experiment, that is the effects that circulating CHV 
neutralizing antibodies would have on subsequent reinfection. 
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By comparing the clinical signs in Table 21 and viral 
isolations in Table 19, with the CHV antibody titers in 
Table 20, it is apparent that a high titer protected dog 
41 from a severe disease but it did not prevent this dog 
from reinfection as CHV was isolated for 9 days postinocula-
tion. Low CHV antibody titers (4-16) seen in all the other 
dogs neither protected the dogs from severe clinical signs 
nor from infection. 
The route of inoculation did not seem to have any 
effect on the clinical symptoms as the infections spread 
from the nasal cavity to the eye and vice versa. 
The environmental temperature at which these dogs were 
maintained had a profound effect on the severity of the 
clinical symptoms that developed, All the dogs maintained 
at a constant normal room temperature developed mild con-
junctivitis and rhinorrhea similar to what was seen in 
experiment·1. However, the clinical symptoms seen in 
the dogs maintained in the varying temperatures were much 
more severe with the exception of dog 41 which had the 
comparatively high preinoculation CHV antibody titer. 
The sneezing which was seen in experiment 6 was again seen 
' in dogs 42, 43 and 44. More severe signs in the 3 doqs in 
experiment 7 was nossibly due to a difference in age, 
The dogs in experiment 7 were 10 weeks old at the onset 
of the experiment which may have accounted for the 
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Table 19. Experiment 7: CHV reisolated from dogs main-
tained at different environmental temperatures 
and inoculated with CHV-270 
Environmental Da~s sam~led 
Dog No. Temperature 2 4 6 9 12 16 20 
41 - varieda ob cc c c 0 0 0 
42 varied c CNP p CN (died) 
43 varied N NP CNP CN (died) 
44 varied N CNP p 0 0 0 0 
45 22 c 0 CNP CN 0 0 0 0 
46 22 c CP CNP N 0 0 0 0 
47 22 c NP NP NP NP 0 0 0 
48 22 c NP CNP N 0 0 0 0 
aTemperature was varied on a 12 hour cycle between 22 C 
and D c. 
bNo CHV isolated. 
cc, N and P represent positive CHV isolations from the 
conjunctival sac, nasal cavity and pharynx, respectively. 
Table 20. 
Dog No. 
41 
42a 
43a 
44 
45 
46 
47 
48 
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Experiment 7: CHV antibody titers of dogs main-
tained at different environmental temperatures 
and inoculated with CHV-270 
Environmental 
Days .. sampled 
temperature 0 7 28 
varied 256 256 
varied 4 8 
variedb 16 16 
varied 4 512 
22 c 16 64 
22 c 16 64 
22 c 4 256 
22 c 16 512 
aoogs 42 and 43 died on day 9 and 11 postinoculation, 
respectively. 
bTemperature was varied on a 12 hour cycle between 
22 C and 0 c. 
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Table 21. Experiment 7: Clinical signs elicited in dogs 
maintained at different environmental tempera-
tures and inoculated with CHV-270 
Dog No, Day Conjunctivitis Rhinorrhea Sneezing 
42 
43 
44 
41 
42 
43 
44 
41 
42 
43 
44 
47 
48 
41 
42d 
43 
44 
45 
.1 
2 
2 
2 
4 
4 
4 
4 
6 
6 
6 
6 
6 
6 
8 
8 
8 
8 
8 
0 
+ + 0 
;!; + 0 
+ 0 0 
+ + 
++ + 
++ + + 
+ 0 0 
++ ++ + 
++ ++ + 
+ 0 + 
0 
0 
0 0 
++ ++ + 
++ ++ + 
+ + 0 
0 
alndicates the condition was present but to a lesser 
degree than +, 
bClinical sion absent, 
C!ndicates a greater severity of the lesion than +, 
dDogs 42 and 4J died on days 9 and 11, respectively. 
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Table 21 • Continued 
Doq No. Day Conjunctivitis Rhinorrhea Sneezinq 
46 8 ± ± 0 
47 8 ± ± 0 
48 8 ± :j; 0 
43d 1 1 ++ ++ + 
44 11 + + + 
44 12 ± ± 0 
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reduced resistance in comparison to the dogs in experiment 
6, which were 16 weeks old. All 4 doqs in experiment 7 
that were maintained at varying environmental temperatures 
were able to maintain a normal bndy temperature during the 
preinoculation period. However, on the 2nd day postinocula-
tion the temperature of all 4 of these dogs dropped (See 
Table 22). 
Clinical symptoms were evident in dogs 42, 43 and 44 by 
day 2 postinoculation. The clinical symptoms in dogs 42 and 
43 increased in severity until day 4 when both dogs had a 
severe conjunctivitis and rhinitis. The conjunctivitis was 
characterized by a severely injected sclera and conjunctiva 
with copious amounts of purulent exudate draining and en-
crusting around the eyes. The rhinitis was characterized by 
a mucopurulent rhinorrhea and sneezing. Figure 6 is a 
photograph of dog 42 on day 6 postinoculation. Dog 44 also 
developed severe con_junctivitis but by day 6 postinoculation 
this dog was showing some improvement while the conditions 
of dogs 42 and 43 continued to deteriorate, Both of these 
dogs lost body weight and condition and their hair coats 
became rough, dry and scaly, The deteriorating condition 
of doos 42 and 43 climaxed in death on day 9 and day 11, 
respectively, Fiqure 7 is a photograph of dog 42 shortly 
after death. 
At the time of death the small intestines of both dons 
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Table 22. Experiment 7: Rectal temperatures of dogs main-
tained at different environmental temperatures 
and inoculated with CHV-27D 
Average 
Environ- pre- Da~s QOStinoculation Dog mental inoculation 
No. tern per a tu re temperature 1 2 4 6 9 
41 varied 1 D1 • 3 1 01 • 2 100.0 99.4 99. fi 99.4 
42 varied 1 D1 • 2 101.2 99.6 98.8 98. D 98.2 
43 varied 1 D1 • 9 101 .4 99,8 1 DD, D 99.D (died) 
44 varied 1 D1 .4 1D1.2 100. 2 99.2 1 00. D 99,D 
45 22 c 1 D1 • 5 1 D1 .4 1 D1 • D 1 D1 • 2 1 D1 .4 1 D1 • D 
46 22 c 1 D1 • 5 1 DD.8 1 D1 .2 1 D1 • 5 1D2.0 1 D2. D 
47 22 c 1 D1 • 3 1 D3. D 1 01 • 8 1 D1 • 6 1D2.8 1D2.4 
48 22 c 1 D1 • 2 1 D1 .6 1D2.8 104 .6 101.6 1 D1 • D 
Figure 6. Dog 42, maintained at varying environmental tem-
peratures, 6 days after intraocular inoculation of 
CHV-270. Note conjunctivitis and ocular discharqe 
Figure 7. Dog 42 on day 9 postinoculation, shortly after 
death. Note the exudate encrusted around the 
eyes and nose 
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were congested and there were microscopic hemorrhages at the 
tips of the villi. Both dogs had foci of pulmonary hemorrhage 
(Figure 8) but the overall histopathological appearance of 
the lungs was one of purulent bronchopneumonia and hyperemia. 
Histopathological examination of the conjunctiva, brain and 
tuibinates revealed a purulent necrotizing conjunctivitis, 
rare glial nodules in the medulla, and a purulent necrotizing 
rhinitis, respectively. Figures 9, 10 and 11 depict the 
above-mentioned lesions, 
Bordetella bronchiseptica was isolated from the lungs 
of both dogs that died, 
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Figure 8. Lung from dog 42, 9 days after intraocular 
inoculation of CHV-27 0 . Note foci of pulmonary 
hemorrhaqes 
Fiqure 9. 
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Conjunctiva from do9 
conjunctivitis. Dog 
nasally with CHV-270 
43. 
43 
Exudative necrotizing 
environmental 
inoculated 
maintained at 
H and E x 
was 
and 
temperatures. 
intra-
var y i no 
72 
88 
Figure 10. Medulla from dog 43 inoculated intranasally 
with CHV-270. Note glial nodule. Hand E x 450 
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• 
Figure 11. Nasal turbinates from dog 43 inoculated with 
CHV-270. Note purulent necrotizinq rhinitis. 
H and E x 72 -
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Experiment 8: 
The Effects of Bordetella bronchiseotica on CHU 
Infections of Dogs maintained at Varying 
Environmental Temperatures 
This experiment was designed to determine the effect 
of ~. bronchiseptica in CHU infection. Varying environmental 
temperature was used, as in experiments 6 and 7, as a factor 
to elicit recognizable symptoms. Four 14-week-old German 
Shepherd crossbred dogs were used for this experiment. 
All dogs were seronagative for CHU on day zero. After a 
5-day adjustment period dogs 51 and 52 were intranasally 
inoculated with 1 ml of a 1 to 2 dilution of a 36 hour~. 
bronchiseptica culture grown in tryptose-phosphate broth. 
Dogs 49 and 50 received 1 ml intranasally of uninoculated 
tryptose-phosphate broth at the same time. All four dogs 
remained symptomless for 7 days at which time ~. bronchi~ 
septica was reisolated from the nasal cavity of dogs 51 
and 52 and from the pharynx of dog 52, Dogs 49 and 50 
remained negative for ~. bronchiseptica. On day 7 all dogs 
were intranasally inoculated with 1 ml of a suspension of 
CHU containing 5,1 x 105 pfu. 
All dogs were observed for 2 weeks after viral inocula-
tion for the appearance of clinical signs which were delayed 
until day 12 ( 5 days after viral inoculation). Dogs under 
similar conditions in previous experiments developed signs 
by day 2 or 3. This delay of symptoms was attributed to a 
malfunction in the chamber which allowed the temperature to 
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rise to 32 C (90 F) during the 0 C (32 F) cycle on day 
9. Clinical symptoms characterized by conjunctivitis, 
rhinorrhea, and sneezing commenced on day 12 and lasted 
until day 17. The severity of the clinical signs was 
essentially the same as described in experiment 6, The 
severity of clinical signs between doqs was similar through-
out the course of the 5-day period, 
On day 15 dog 50 became positive for g. bronchiseptica, 
by bacterial isolation. Dog 49 remained negative for g. 
bronchiseptica while dogs 51 and 52 remained positive 
throughout the e~periment, 
Table 23. Experiment 8: CHV antibody titers in dogs after 
intranasal inoculation of CHV-270 
Days sampled 
Dog No, 0 21 
49 <2 64 
50 <2 64 
51a <2 16 
52a <2 16 
aDog 51 and dog 52 were inoculated with Q. bronchi-
septica intranasally on day zero. 
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DISCUSSION 
CHV as a Pathogen of the Respiratory Tract 
The CHV has been reported to cause a relatively mild 
or inapparent upper respiratory infection in non-neonatal 
dogs (2, 116), However, the CHV isolated by Karpas tl al, 
(66) was reported to cause canine tracheobronchitis under 
natural as well as experimental conditions, It is impossible 
to draw conclusions from these conflicting reports as the 
two groups of workers were using different strains of CHV, 
Although cross SVN tests between CHV-270 and CHV F-205 
conducted in this study indicate that these two strains 
are serologically similar they may differ biochemically~ 
which could be responsible for a difference in pathogenicity 
as. seen in the case of!!• hominis type 1 and type 2 (10, BO). 
This is an acceptable theory as to why there are conflicting 
reports of pathogenicity using these two strains of virus 
although it does not seem to be the right theory on the 
basis of the experiments performed in this study, 
The results of intranasal inoculation of dogs main-
tained at normal environmental temperatures with CHV in 
this study would support the findings of Appel tl al· (2), 
their findings being that CHV causes a respiratory infection 
which is mild or inapparent in non-neonatal dogs, Throughout 
the experiments described previously, dogs inoculated intra-
nasally with CHV-270 f~iled to show the symptoms of canine 
I . 
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tracheobronchitis described by Karpas et al. (66 }, 
Karpas et al. (67) isolated CHV from both clinically 
ill and normal dogs in a group of 75 dogs. CHV was isolated 
from 7 of 45 clinically normal dogs and from only 5 of 30 
dogs with clinical signs of respiratory disease destribed 
as canine tracheobronchitis. With these kinds of results 
it would seem questionable that CHV was the cause of this 
disease, It is possible that the CHV infection in this 
group of dogs was c.oincidenta 1, or perhaps only one of 
se~eral contributing factors to the tracheobronchitis. 
Other workers (12) .have isolated. CHV from dogs with respira-
tory disease but little significance has been placed on 
the findings because of the low incidence of recovery and 
the recovery of other agents from these dogs. Kar pas et tl• 
(67) were able to produce the typical paroxysmal cough 
associated with canine tracheobronchitis in only three of 
fifteen dogs inoculated intranasally with CHV, 
In summary, the role of the CHV as a respiratory 
pathogen of dogs maintained at normal environmental condi-
tions, as defined in this study, completely supports the 
findings of Appel tl ll• (2). Both CHV F-205 and CHV-270 
are only mildly pathogenic for the canine respiratory tract 
under normal circumstances. No conclusions can be drawn 
between the pathogenicity of these two isolates and the 
British isolate of Wright and Cornwell (116) which causes no 
respiratory symptoms, As explained previously, the difference 
j 
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in pathogenicity may actually be due to subtle differences 
in the virus isolates rather than in host susceptibility, 
host microbial flora, or acuity of the workers• observations~· 
It is apparent from this study that the clinical 
respiratory disease can be increased dramatically when dogs 
are maintained at cyclic environmental temperatures between 
zero and 22 C (32-72 F) as in experiments 6, 7 and 8. 
Previous work by Aurelian (7) has shown that 1.!l vitro 
yields of CHV were dependent on the temperature of cultiva-
tion. Temperatures above and below 37 C resulted in de-
creased yield of CHV. Carmichael et al. (26) theorized --
that increasing body temperature may be the cause of 
decreased susceptibility of the dog to CHV with increasing 
age •. Their experiments showed that increasing the environ-
mental temperature in which the CHV infected neonatal pups 
were maintained would decrease the pathogenicity. These 
same workers maintained 4 to 8-week-old dogs in a hypo-
thermic state for 45-48 hours by tranquilization and found 
that these dogs had significantly greater amounts of viral 
antigen i~ their tissues, as demonstrated by the fluorescent-
antibody technique,. and by the greater amount of recoverable 
CHV from the tissues in comparison to control dogs infected 
with CHV and maintained at normal temperatures. They were 
also able to demonstrate histological lesions in the dogs 
in a hypothermic state while control dogs lacked such lesions. 
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It is hypothesized that in experiments 6, 7, and 8 the 
environmental temperature was lowered sufficiently to cool 
the respiratory epithelium to a tempera tu re optima 1 for 
CHV replication, This could explain the increased patho-
genicity of CHV respiratory infection in the dogs maintained 
at lower environmental temperatures, In experiment 7 
there was an added benefit of lowering the environmental 
temperature which was the resultant reduction in body 
temperature of the 4 dogs, It can be postulated that this 
lowered body temperature also added to the increased severity 
of the CHV infections in this experiment which resulted in 
the death of two of the dogs, The lowered body temperature 
seen in the 4 dogs was not due entirely to the lowered 
environmental temperature because there was no reduction 
in body temperature in these dogs during the 5-day adjust-
ment period in which environmental temperature was lowered 
as it was after inoculation, It appears that possibly a 
combination of the lowered environmental temperature and 
the CHV infection caused the lowering of the body tempera-
ture, The reason that the 4 dogs in experiment 7 had a 
reduced body temperature while dogs in experiments 6 and 8 
had normal body temperatures during these experiments is 
probably due to age and general body conditioning, Dogs 
in experiment 7 were 4 to 6 weeks younger and appeared to 
have less body fat than dogs in experiments 6 and 8, The 
I 
\ 
I 
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fact that the dogs in experiment 7 eame from diPferent 
sources than the dogs in experiments 6 and 8 caused concern 
because of the ptobable difference in resident microflora 
which might also account for variation in the severity of 
the disease. The isolation of B, br-0nchiseptica from the 
lungs of both dogs that died in experiment 7 initiated the 
interest in the auxiliary role that !· bronchiseotica might 
have in a CHV infection, Appel et al. (4) stated that --
!. bronchiseptica were the most common bacteria isolated 
from dogs with respiratory disease in their study and that 
bacteria are very important secondary invaders in canine 
respiratory infections. Experiment 8 failed to show that 
concurrent !· bronchiseptica and CHV infections caused an 
increase in respiratory symptoms over those caused by CHV 
alone. However, it is possible that !. bronchiseptica was 
iriiportant as a secondary bacterial invader which contributed 
to the demise of dogs 42 and 43 in experiment 7. 
CHV as a Pathogen of the Genital Tract 
Previous to the report by Paste and King (90) of the 
isolation of CHV from the genital tract of dogs experiencing 
infertility, abortion, and stillbirths, little attention 
had been paid to CHV as a genital tract pathogen of dogs. 
It had been reported that CHV F-205 caused a mild inflammation 
of the vaginal mucosa after intravaginal inoculation (2). 
In this study we were able to show that CHV-270 was patho-
genic f6r the genital tract of both male and female dogs. 
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Paste and King described the early lesions they saw as 
·vesicular in nature, later becoming "pock-like." The 
lesions seen in this study also looked vesicular, having 
glistening white surfaces, However, these lesions, which 
on histological examination were found to be lymphoid 
nodules rather than vesicles, never became ''pock-like." 
Other differences between the lesions reported by 
Paste and King and those observed in this study were the 
duration of the visible lesions, the length of the incuba-
tion period, and the incidence of genital infection after 
intravaginal inoculation of CHV, Paste and King (90) re-
ported that vesicles last for 14 to 18 days in naturally-
infected dogs while the vaginal lesions in this study 
lasted only 4 to 5 days. Also in this study, bitches 
previously unexposed to CHV developed vaginal lesions 2 
days postinoculation and 100 percent of the dogs developed 
lesions while Paste and King (90) reported that only 1 of 
3 bitches inoculated intravaginally developed lesions and 
these lesions developed 7 days postinoculation, 
Paste and King (90) did not report on any histopath-
ological studies of these vaginal lesions so it is not 
possible to determine if the lesions they reported were 
lymphoid nodules rather than vesicles. It is highly pro-
bable that the lesions these authors have described are 
quite similar to the genital lesions experimentally pro-
duced in this study, However, it is interesting to note 
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that Paste (89) has reported that even though his isolate 
(CHV-BR) was serologically similar to CHV F-205 on the 
basis of neutralization and immunofluorescence tests there 
were marked differences between these two isolates by 
virtue of the CPE produced in DKC. Unfortunately it was 
not possible to obtain the CHV-BR strain so that pathogenicity 
comparisons could be made. In MOCK cells CHV-270 and 
CHV F-205 produce a similar CPE and an approximately equal 
number of intranuclear inclusions. It is therefore reason-
able to assume that CHV-BR also differs in vitro with 
CHV-270 as well as differing in .lLilLQ. as described previously. 
Paste (89) has noted the emergence of a non-syncytial CPE 
variant that produces CPE identical to that described for 
other CHV isolates. 
It is interesting to note that all three of these 
isolates, CHV F-205, CHV-270, and CHV-BR have been isolated 
from different anatomical sites of dogs with different 
clinical conditions. Posts (89) has hypothesized that 
like tl• hominis the site of isolation may affect the type· 
of CPE produced. 
Immunological and Epidemiological Aspects of CHV 
All the dogs in this study inoculated with CHV-270 
developed circulating neutralizing antibodies, which 
ranged in titer from 4 to 64, by day 28 postinoculation. 
The dogs in experiment 5, which were inoculated with CHV-33 
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by the intranasal and subcutaneous routes, developed similar 
antibody titers but the 4 dogs inoculated intravaginally 
failed to develop any neutralizing antibodies. These 
4 dogs did however develop vaginal lesions and virus was 
reisolated for 6 days postinoculation from the vagina only, 
indicating that the infection only involved the genital 
tract. Upon challenge with CHV-270, neutralizing anti-
bodies developed in the 4 dogs previously inoculated 
intravaginally with CHV-33, and again the virus was only 
isolated from the vagina. It would appear from these 
results that CHV-33 was less antigenic than CHV-270 at 
least in regard to stimulating humoral antibodies from a 
vaginal infection. After challenge with CHV-270 it became 
evident that CHV-33 had provided a degree of protection 
but this protection was incomplete. The protection could 
not be attributed entirely to circulating antibody because 
the 4 dogs inoculated intravaginally with CHV-33 did not 
develop circulating antibodies yet they were partially 
protected when challenged with CHV-270. It is possible 
that local secretory antibody (IgA) from the vaginal 
mucosa was stimulated by the CHV-33 infection thus pro-
viding some protecti.on to subsequent CHV vaginal infections, 
Protection was based on the lack of spread of the virus 
in the dog and the lack of vaginal lesions, The challenge 
virus did not spread from the vagina in the 12 dogs pre-
\ 
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viously inoculated with CHV-33 as compared to the control 
dogs from which the challenge virus was isolated from the 
conjunctiva, nasal cavity and the pharynx as well as 
the vagina. With respect to the development of vaginal 
lesions after challenge, only 4 of 12 dogs previously 
infected with CHV-33 developed lymphoid nodules character-
istic of a CHV vaginal infection, whereas the control 
dogs in experiment 5 and all the dogs in experiment 4 
developed vaginal lesions, including lymphoid nodules, 
when inoculated with CHV-270, 
Low levels of circulating antibodies (4 to 16) in 
the dogs in experiment 7 did not seem to protect them from 
CHV respiratory infections, However, high-level.antibodies 
protected against CHV respiratory disease as indicated 
by the fact that one dog with an antibody titer of 256 
did not develop the respiratory symptoms which the other 
dogs developed when exposed to the lowered environmental 
temperature, 
Having established that CHV-270 is a pathogen of the 
respiratory tract, the genital tract and occasion~lly the 
conjunctiva and that previous exposure to CHV can have an 
effect on subsequent infections, it is interesting to 
examine the whole CHV disease complex, The fact remains 
that the most important aspect of this virus in' the dog 
population is in its ability to kill neonatal dogs, 
. ' 
' 
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CHV respiratory, genital and conjunctiva! infections are im-
portant primarily as a means of maintaining and trans-
' mitting the virus in nature. These three conditions caused 
I by CHV could also be important to the veterinary diagnosti-
cian in the differential diaqnosis of disease in individual 
dogs in spite of the fact that under normal environmental 
conditions the conjunctivitis, genital and respiratory tract 
! diseases would be self-limiting. CHV infections may also 
cause stillbirths, abortions and infertility, but these are 
conditions in which CHV has been incriminated by only one 
group of investigators to date (90). If a CHV infection 
were to occur in a dog colony, breeding establishment or any 
premises where large numbers of dogs are bred and housed, the 
situation could potentially be very serious. For example a 
stud dog in a breedinq colony with a CHV infection could 
infect several bitches resultinq in the death of pups born 
subsequent to the infection. Paste and King (90) found that 
the CHV infections recurred so it is possible that with both 
. ' . 
viral latency and recurrence it would be impassible to rid a 
colony of CHV short of depopulating. 
It would be possible to have a carrier bitch in a 
population that had normal litters of pups while acting as 
a source of infection for other dogs in the colony. 
Huxsoll and Hemelt (57) suggested that it was maternal. anti-
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bodies that protected these pups born to bitches that had 
previous litters die of a CHV infection. A situation could 
occur where the stress of whelping c~uld cause a recurrence 
of a CHV infectibn in a carrier bitch but the litter would 
be protected. by maternal antibodies, Thus the bitch would 
go unnoticed as the source of the infection, 
Any indication that a colony of dogs has had contact 
with CHV, such as the presende of circulating neutralizing 
antibodies, would make one wary of the possibility of CHV 
infections in neonatal pups. However, the results of 
serological tests on day zero in experiment 7 indicate 
that all 8 dogs had either had CHV infection or possessed 
maternal antibodies passed frnm their dam. Although no 
determinations have been made of how long maternal anti-
bodies to CHV are maintained, it seems unlikely that 
such tif~rs would last 10 weeks. Regardless of whether 
the antibodies were stimulated in the pups or were maternal, 
CHV had to be present at some time in the commercial 
colony from which these dogs were obtained. The owner (53) 
of this colony reported that all dogs that died in the 
colony were routinely necropsied and no lesions typical of 
CHV infections. in neonatal dogs had been noted. furth~rmore, 
no increase in
1 
neonatal deaths had been reported, It was 
also reported by the owner.that a ~scent check showed that 
17 of 20 serum samples from producing bitches were positive 
• I 
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for CHV antibodies. 
One can suggest many reasons why this colony has dogs 
with CHV circulating antibodies without neonatal deaths. 
For example these titers could be due to a closely-related 
virus that has yet to be discovered or possibly there are 
inapparent CHV infections in the colony that are caused 
by less pathogenic strains of this virus. Yet another 
possibility is that the environmental conditions in the 
colony, primarily the temperature, are such that infections 
in neonatal dogs do not progreis to the point of ~ clinical 
disease. 
One can easily ascertain that there are many unanswered 
questions about CHV especially with regard to latent and 
recurring infections, inapparent infections, and the role 
of circulating antibodies in a population of dogs. The 
recent findings by Paste and King (90) and the findings 
reported in this study add the role of CHV in genital 
infections and the resultant infertility and abortions to 
the list of areas that need to be more completely elucidated. 
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SUMMARY 
This study was designed to determine the disease-
producing potential of CHV-270 in non-neonatal dogs with 
particular emphasis on the respiratory and genital tracts, 
CHV respiratory infections were studied ih dogs inrected 
:dlith CHV-270 and maintained at normal environmental 
temperatures as well as dogs infected and maintained at 
varied environmental temperatures, Experimentally-infected 
dogs were observed for clinical signs and sampled periodically 
to determine if CHV infection had become established and 
to what extent CHV was shed from the infected dogs. CHV 
antibody titers were monitored to determine the immunologi-
cal response to the CHV infections. 
Several interesting observations were made from these 
experiments, ·one of these observations was that with an 
added environmental stress, specifically maintenance of 
dogs at cyclic environmental temperatures between 0 C anrl 
22 C, dogs experimentally infected with CHV-270 developed 
more severe signs than infected doos maintained at a normal 
environmental temperature (22 C). Dogs maintained on the 
variable temperature regimen developed clinical signs of 
upper respiratory disease such as sneezing anrl severe 
rhinorrhea. Two such dogs died and upon postmortem 
examination a purulent rhinitis and conjunctivitis was 
present and there were foci O·f pulmonary hemorrh~ge, 
1 05 
Although !l_. bronchiseptica was isolated from the .lungs 
of bath of these dogs it was not considered a primary 
etiological agent. !l_. bronchiseptica was considered a 
secondary bacterial invader since subsequent experiments 
showed that dual infections with Ji, bronthiseptica and 
CHV-270 were no more severe than CHV-270 infection alone. 
It was concluded that the lowering of the environ-
mental temperature probably caused a lowering of the 
temperature of the respiratory tract e pi the lium to a 
temperature that was closer to the optimum for CHV repli-
cation, thus alla.uiing the virus to replicate optimally 
and precipitate the clini.cal signs observed, The 2 dogs 
that died were in a oroup of 4 that, unlike othar dogs 
infected With CHV and maintained at the variable environ-
menta 1 temperature, had lowered body temperatures. Again 
it was theorized that the lowered temperature allowed for 
greater CHV replication and thus the mare severe clinical 
disease. 
Another observation made from this study was the fact 
that CHV-270 caused a genital infection in both the male 
and female dog. The infection in the female was quite 
severe, however in doqs of both sexes the genital disease 
was self-limiting. Female dogs were primarily used for 
the study of the CHV qenital infections because of the 
ease by which the lesions could be observed in compa.rison 
I 
I ., 
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to the difficulty of observing lesions in the male dog. 
The gross lesions consisted of several small glistening 
white raised areas in the genital mucosa with accompanying 
submucosal and petechial hemorrhages. Histopathological 
examination.· of the genital mucosa of both male and female 
dogs revealed that the raised areas were focal lymphoid 
nodules. These genital lesions could be consistently 
reproduced in female dogs not previously exposed to CHV. 
Several dogs experienced a mild to severe conjunctivitis 
after intraocular inoculation of CHV-270 or after the spread 
of this virus to the eye. The mechanism of CHV spread 
within the dog is not completely understood. Viral spread 
from the respiratory tract to the genital tract, or .!!1.£.€!. 
v~rsa, by licking. is a probable mode of spread, but it is 
not the only mechanism of spread as was shown by the fact 
that dogs inoculated subcutaneously with CHV-270 shed virus 
from the oral and nasal cavities and the vagina. 
The immunological response, as determined by the presence 
of circulating CHV-neutralizing antibodies, was consistently 
present after CHV-270 inoculation. CHV-33 stimulated an 
antibody response when inoculated subcutaneously and intra-
nasally, but no circulating CHV antibodies were present 
after intravaginal inoculation. When these dogs were 
inoculated intranasally, intravaginally or subcutaneously 
with CHV-33 they were less susceptible to intravaginal 
challenge with CHV-270 than uninoculated dogs •. However, 
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dogs that had moderate levels of CHV neutralizing anti-
bodies (titers of 4 to 16) were as susceptible to CHV-270 
inoculated intranasally as dogs with no antibody titers. 
One dog with a CHV antibody titer of 256 showed increased 
resistance to CHV-270 inoculated intranasally, however 
this dog did develop conjunctivitis and shed CHV. It 
appears that moderate levels of circulating CHV-neutralizing 
antibodies do not protect against CHV-270 respiratory 
infections but do partially protect against genital CHV 
infections. 
I 
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